BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 772104 Clc1ccc(c(Cl)c1)-c1cccc2ncnn12 InChI=1S/C12H7Cl2N3/c13-8-4-5-9(10(14)6-8)11-2-1-3-12-15-7-16-17(11)12/h1-7H BHYCFRGXFQGMDR-UHFFFAOYSA-N 50239899 CHEMBL4103861::US10287286, Example 1 Prolyl hydroxylase EGLN2 Homo sapiens 677 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239899&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44449149 85715558 CHEMBL4103861 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772105 Clc1ccc(cc1)-c1cccc2ncnn12 InChI=1S/C12H8ClN3/c13-10-6-4-9(5-7-10)11-2-1-3-12-14-8-15-16(11)12/h1-8H QNCJGXUDXWWAKZ-UHFFFAOYSA-N 50239898 CHEMBL4070540::US10287286, Example 2 Prolyl hydroxylase EGLN2 Homo sapiens 54.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239898&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 11396245 85715334 CHEMBL4070540 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772106 N#Cc1ccc(cc1)-c1cccc2ncnn12 InChI=1S/C13H8N4/c14-8-10-4-6-11(7-5-10)12-2-1-3-13-15-9-16-17(12)13/h1-7,9H DEYMFBHALUHGST-UHFFFAOYSA-N 50239937 CHEMBL4083851::US10287286, Example 3 Prolyl hydroxylase EGLN2 Homo sapiens 34.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239937&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 8UY 5V1B,5V18 44448563 85714607 CHEMBL4083851 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772107 Cc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C14H10N4/c1-10-6-13(18-14(7-10)16-9-17-18)12-4-2-11(8-15)3-5-12/h2-7,9H,1H3 OAEPDIOJHOTRRM-UHFFFAOYSA-N 50239890 CHEMBL4095005::US10287286, Example 4 Prolyl hydroxylase EGLN2 Homo sapiens 39.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239890&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 21947630 85715424 CHEMBL4095005 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772108 Fc1cc(ccc1C#N)-c1cccc2ncnn12 InChI=1S/C13H7FN4/c14-11-6-9(4-5-10(11)7-15)12-2-1-3-13-16-8-17-18(12)13/h1-6,8H CUZZZFBECBOGRY-UHFFFAOYSA-N 50239883 CHEMBL4090769::US10287286, Example 5 Prolyl hydroxylase EGLN2 Homo sapiens 10.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239883&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448590 85714640 CHEMBL4090769 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772109 Fc1cc(cc(F)c1C#N)-c1cccc2ncnn12 InChI=1S/C13H6F2N4/c14-10-4-8(5-11(15)9(10)6-16)12-2-1-3-13-17-7-18-19(12)13/h1-5,7H WWTWZEXZURTRAX-UHFFFAOYSA-N 50239915 CHEMBL4067559::US10287286, Example 6 Prolyl hydroxylase EGLN2 Homo sapiens 34.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239915&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44449064 85715429 CHEMBL4067559 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772110 Fc1cc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C13H7FN4/c14-11-6-9(7-15)4-5-10(11)12-2-1-3-13-16-8-17-18(12)13/h1-6,8H KIMDFRBRYJBQCN-UHFFFAOYSA-N 50239921 CHEMBL4075128::US10287286, Example 7 Prolyl hydroxylase EGLN2 Homo sapiens 50.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239921&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448896 85715138 CHEMBL4075128 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772111 Cc1cc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C14H10N4/c1-10-7-11(8-15)5-6-12(10)13-3-2-4-14-16-9-17-18(13)14/h2-7,9H,1H3 URBXKEHMAICHMQ-UHFFFAOYSA-N 50239880 CHEMBL4076493::US10287286, Example 8 Prolyl hydroxylase EGLN2 Homo sapiens 74.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239880&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448477 85714497 CHEMBL4076493 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772112 Fc1cc(Cl)ccc1-c1cccc2ncnn12 InChI=1S/C12H7ClFN3/c13-8-4-5-9(10(14)6-8)11-2-1-3-12-15-7-16-17(11)12/h1-7H AMBSETOAQSIXOU-UHFFFAOYSA-N 384303 5-(4-chloro-2- fluorophenyl)- [1,2,4]triazolo [1,5-a]pyridine::US10287286, Example 9 Prolyl hydroxylase EGLN2 Homo sapiens 307 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384303&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540771 404853585 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772113 Clc1cc(ccc1C#N)-c1cccc2ncnn12 InChI=1S/C13H7ClN4/c14-11-6-9(4-5-10(11)7-15)12-2-1-3-13-16-8-17-18(12)13/h1-6,8H MHHKFALIEJDOHF-UHFFFAOYSA-N 50239881 CHEMBL4062995::US10287286, Example 10 Prolyl hydroxylase EGLN2 Homo sapiens 3890 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239881&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448480 85714500 CHEMBL4062995 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772114 FC(F)(F)c1cc(ccc1C#N)-c1cccc2ncnn12 InChI=1S/C14H7F3N4/c15-14(16,17)11-6-9(4-5-10(11)7-18)12-2-1-3-13-19-8-20-21(12)13/h1-6,8H NPQUMGVYGVCXGJ-UHFFFAOYSA-N 50239882 CHEMBL4085434::US10287286, Example 11 Prolyl hydroxylase EGLN2 Homo sapiens 1874 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239882&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448515 85714542 CHEMBL4085434 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772115 Fc1cc(ccc1Cl)-c1cccc2ncnn12 InChI=1S/C12H7ClFN3/c13-9-5-4-8(6-10(9)14)11-2-1-3-12-15-7-16-17(11)12/h1-7H ITXUXQHFLAHBEV-UHFFFAOYSA-N 384316 5-(4-chloro-3- fluorophenyl)- [1,2,4]triazolo [1,5-a]pyridine::US10287286, Example 12 Prolyl hydroxylase EGLN2 Homo sapiens 452 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384316&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540657 404853598 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772116 Cc1cc(ccc1C#N)-c1cccc2ncnn12 InChI=1S/C14H10N4/c1-10-7-11(5-6-12(10)8-15)13-3-2-4-14-16-9-17-18(13)14/h2-7,9H,1H3 VWOHQDZHCQQGLW-UHFFFAOYSA-N 50239922 CHEMBL4069766::US10287286, Example 13 Prolyl hydroxylase EGLN2 Homo sapiens 829 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239922&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448931 85715193 CHEMBL4069766 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772117 N#Cc1ccc(nc1)-c1cccc2ncnn12 InChI=1S/C12H7N5/c13-6-9-4-5-10(14-7-9)11-2-1-3-12-15-8-16-17(11)12/h1-5,7-8H KFOGCVZDTSAKDZ-UHFFFAOYSA-N 50239907 CHEMBL4065934::US10287286, Example 14 Prolyl hydroxylase EGLN2 Homo sapiens 272 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239907&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448853 85715080 CHEMBL4065934 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772118 N#Cc1ccc(cn1)-c1cccc2ncnn12 InChI=1S/C12H7N5/c13-6-10-5-4-9(7-14-10)11-2-1-3-12-15-8-16-17(11)12/h1-5,7-8H YUYPQDVCXUWEDQ-UHFFFAOYSA-N 50239909 CHEMBL4059941::US10287286, Example 15 Prolyl hydroxylase EGLN2 Homo sapiens 171 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239909&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 11604063 85715289 CHEMBL4059941 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772119 N#Cc1ccc(cc1)-c1nccc2ncnn12 InChI=1S/C12H7N5/c13-7-9-1-3-10(4-2-9)12-14-6-5-11-15-8-16-17(11)12/h1-6,8H TYXLWIGNDNJNFS-UHFFFAOYSA-N 384327 4-{[1,2,4] triazolo[1,5-c] pyrimidin-5- yl}benzonitrile::US10287286, Example 16 Prolyl hydroxylase EGLN2 Homo sapiens 3941 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384327&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540690 404853605 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772120 Fc1cc(ccc1C#N)-c1nccc2ncnn12 InChI=1S/C12H6FN5/c13-10-5-8(1-2-9(10)6-14)12-15-4-3-11-16-7-17-18(11)12/h1-5,7H UCFYQUDHDDRQFP-UHFFFAOYSA-N 384329 2-fluoro-4- {[1,2,4]triazolo [1,5-c]pyrimidin- 5-yl} benzonitrile::US10287286, Example 17 Prolyl hydroxylase EGLN2 Homo sapiens 2156 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384329&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540382 404853607 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772121 Cc1ccc2ncnn2c1-c1ccc(cc1)C#N InChI=1S/C14H10N4/c1-10-2-7-13-16-9-17-18(13)14(10)12-5-3-11(8-15)4-6-12/h2-7,9H,1H3 BXRZVLHTIWMPBC-UHFFFAOYSA-N 50239886 CHEMBL4063144::US10287286, Example 18 Prolyl hydroxylase EGLN2 Homo sapiens 460 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239886&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448677 85714768 CHEMBL4063144 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772122 Cc1ccc2ncnn2c1-c1ccc(C#N)c(F)c1 InChI=1S/C14H9FN4/c1-9-2-5-13-17-8-18-19(13)14(9)10-3-4-11(7-16)12(15)6-10/h2-6,8H,1H3 UWZQEPNPYYQBNV-UHFFFAOYSA-N 384333 2-fluoro-4-{6- methyl-[1,2,4] triazolo[1,5-a] pyridin-5-yl} benzonitrile::US10287286, Example 19 Prolyl hydroxylase EGLN2 Homo sapiens 665 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384333&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540674 404853609 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772123 Cc1nc(ccc1-c1cc(Cl)cc2ncnn12)C#N InChI=1S/C13H8ClN5/c1-8-11(3-2-10(6-15)18-8)12-4-9(14)5-13-16-7-17-19(12)13/h2-5,7H,1H3 PWQKUIKFWFPZEP-UHFFFAOYSA-N 384335 5-{7-chloro- [1,2,4]triazolo [1,5-a]pyridin- 5-yl}-6- methylpyridine- 2-carbonitrile::US10287286, Example 20 Prolyl hydroxylase EGLN2 Homo sapiens 1955 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384335&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540513 404853611 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772124 N#Cc1ncc(cn1)-c1cccc2ncnn12 InChI=1S/C11H6N6/c12-4-10-13-5-8(6-14-10)9-2-1-3-11-15-7-16-17(9)11/h1-3,5-7H QOMVEWRHNWLNQR-UHFFFAOYSA-N 50239908 CHEMBL4093533::US10287286, Example 21 Prolyl hydroxylase EGLN2 Homo sapiens 84.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239908&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448857 85715085 CHEMBL4093533 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772125 N#Cc1cnc(cn1)-c1cccc2ncnn12 InChI=1S/C11H6N6/c12-4-8-5-14-9(6-13-8)10-2-1-3-11-15-7-16-17(10)11/h1-3,5-7H PGPARSKOVPYPPP-UHFFFAOYSA-N 50239925 CHEMBL4085789::US10287286, Example 22 Prolyl hydroxylase EGLN2 Homo sapiens 1283 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239925&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 10076169 85714466 CHEMBL4085789 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772126 Fc1c(F)c(ccc1C#N)-c1cccc2ncnn12 InChI=1S/C13H6F2N4/c14-12-8(6-16)4-5-9(13(12)15)10-2-1-3-11-17-7-18-19(10)11/h1-5,7H PAQNXWWTZCDJGC-UHFFFAOYSA-N 50239928 CHEMBL4094977::US10287286, Example 23 Prolyl hydroxylase EGLN2 Homo sapiens 67.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239928&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540317 386048286 CHEMBL4094977 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772127 Fc1cc(cnc1C#N)-c1cccc2ncnn12 InChI=1S/C12H6FN5/c13-9-4-8(6-15-10(9)5-14)11-2-1-3-12-16-7-17-18(11)12/h1-4,6-7H SBAVDTSBJDDFOK-UHFFFAOYSA-N 384342 3-fluoro-5- {[1,2,4]triazolo [1,5-a]pyridin- 5-yl}pyridine- 2-carbonitrile::US10287286, Example 24 Prolyl hydroxylase EGLN2 Homo sapiens 99.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384342&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540372 404853615 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772128 Cc1cc(ncc1-c1cccc2ncnn12)C#N InChI=1S/C13H9N5/c1-9-5-10(6-14)15-7-11(9)12-3-2-4-13-16-8-17-18(12)13/h2-5,7-8H,1H3 IQRKYLDFWJMPQL-UHFFFAOYSA-N 384344 4-methyl-5- {[1,2,4]triazolo [1,5-a]pyridin- 5-yl}pyridine- 2-carbonitrile::US10287286, Example 25 Prolyl hydroxylase EGLN2 Homo sapiens 56.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384344&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540479 404853617 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772129 Cc1cc(cc(C)c1-c1cccc2ncnn12)C#N InChI=1S/C15H12N4/c1-10-6-12(8-16)7-11(2)15(10)13-4-3-5-14-17-9-18-19(13)14/h3-7,9H,1-2H3 RKMWDUWATTXHKI-UHFFFAOYSA-N 50239911 CHEMBL4094084::US10287286, Example 26 Prolyl hydroxylase EGLN2 Homo sapiens 197 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239911&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44449015 85715335 CHEMBL4094084 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772130 N#Cc1ccc(nn1)-c1cccc2ncnn12 InChI=1S/C11H6N6/c12-6-8-4-5-9(16-15-8)10-2-1-3-11-13-7-14-17(10)11/h1-5,7H HENICZDKXPFILD-UHFFFAOYSA-N 50239906 CHEMBL4103717::US10287286, Example 27 Prolyl hydroxylase EGLN2 Homo sapiens 1400 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239906&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 11386357 85715512 CHEMBL4103717 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772131 Cc1nc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C13H9N5/c1-9-11(6-5-10(7-14)17-9)12-3-2-4-13-15-8-16-18(12)13/h2-6,8H,1H3 VTCJIPLHTZNBOP-UHFFFAOYSA-N 384351 6-methyl-5- {[1,2,4]triazolo [1,5-a]pyridin- 5-yl} pyridine-2- carbonitrile::US10287286, Example 28 Prolyl hydroxylase EGLN2 Homo sapiens 93.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=384351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=384351&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540664 404853624 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772132 Cc1cc(C#N)c(F)cc1-c1cccc2ncnn12 InChI=1S/C14H9FN4/c1-9-5-10(7-16)12(15)6-11(9)13-3-2-4-14-17-8-18-19(13)14/h2-6,8H,1H3 SILWQYKKPNLLJK-UHFFFAOYSA-N 50239927 CHEMBL4086321::US10287286, Example 29 Prolyl hydroxylase EGLN2 Homo sapiens 145 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239927&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 10347927 85714604 CHEMBL4086321 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772133 Clc1cc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C13H7ClN4/c14-11-6-9(7-15)4-5-10(11)12-2-1-3-13-16-8-17-18(12)13/h1-6,8H RTUWOCQLXWOWRJ-UHFFFAOYSA-N 50239929 CHEMBL4076409::US10287286, Example 30 Prolyl hydroxylase EGLN2 Homo sapiens 136 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239929&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 10005080 85714424 CHEMBL4076409 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772134 COc1cc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C14H10N4O/c1-19-13-7-10(8-15)5-6-11(13)12-3-2-4-14-16-9-17-18(12)14/h2-7,9H,1H3 ZKWFDHAHAZNGPP-UHFFFAOYSA-N 50239917 CHEMBL4068120::US10287286, Example 31 Prolyl hydroxylase EGLN2 Homo sapiens 141 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239917&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448932 85715195 CHEMBL4068120 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772135 Cc1cc(cnc1-c1cccc2ncnn12)C#N InChI=1S/C13H9N5/c1-9-5-10(6-14)7-15-13(9)11-3-2-4-12-16-8-17-18(11)12/h2-5,7-8H,1H3 KOHORTSQJIXYIF-UHFFFAOYSA-N 385608 5-methyl-6- {[1,2,4]triazolo [1,5-a]pyridin- 5-yl}pyridine- 3-carbonitrile::US10287286, Example 32 Prolyl hydroxylase EGLN2 Homo sapiens 506 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385608&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540399 404854788 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772136 CCc1cc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C15H12N4/c1-2-12-8-11(9-16)6-7-13(12)14-4-3-5-15-17-10-18-19(14)15/h3-8,10H,2H2,1H3 WZNBZKZNQYRPKE-UHFFFAOYSA-N 50239920 CHEMBL4074091::US10287286, Example 33 Prolyl hydroxylase EGLN2 Homo sapiens 6109 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239920&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448859 85715087 CHEMBL4074091 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772137 Cc1cc(cc(F)c1-c1cccc2ncnn12)C#N InChI=1S/C14H9FN4/c1-9-5-10(7-16)6-11(15)14(9)12-3-2-4-13-17-8-18-19(12)13/h2-6,8H,1H3 GRRJHIVATRJJEV-UHFFFAOYSA-N 50239912 CHEMBL4064841::US10287286, Example 34 Prolyl hydroxylase EGLN2 Homo sapiens 223 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239912&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 21054485 85715380 CHEMBL4064841 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772138 Nc1cc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C13H9N5/c14-7-9-4-5-10(11(15)6-9)12-2-1-3-13-16-8-17-18(12)13/h1-6,8H,15H2 HBNUXWFTHWHLHL-UHFFFAOYSA-N 50239919 CHEMBL4104731::US10287286, Example 35 Prolyl hydroxylase EGLN2 Homo sapiens 58.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239919&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448856 85715084 CHEMBL4104731 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772139 Brc1cc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C13H7BrN4/c14-11-6-9(7-15)4-5-10(11)12-2-1-3-13-16-8-17-18(12)13/h1-6,8H RSEOIWHIXPKXNI-UHFFFAOYSA-N 385616 3-bromo-4- {[1,2,4]triazolo [1,5-a]pyridin- 5-yl} benzonitrile::US10287286, Example 36 Prolyl hydroxylase EGLN2 Homo sapiens 67.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385616&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540604 404854796 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772140 N#CC1CCN(CC1)c1cccc2ncnn12 InChI=1S/C12H13N5/c13-8-10-4-6-16(7-5-10)12-3-1-2-11-14-9-15-17(11)12/h1-3,9-10H,4-7H2 LVBPHSQMFKIYMO-UHFFFAOYSA-N 50239902 CHEMBL4082314::US10287286, Example 37 Prolyl hydroxylase EGLN2 Homo sapiens 280 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239902&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 11316670 85715285 CHEMBL4082314 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772141 N#CC1=CC=[N](C=C1)c1ccnc2ncnn12 InChI=1S/C11H7N6/c12-7-9-2-5-16(6-3-9)10-1-4-13-11-14-8-15-17(10)11/h1-6,8H XDCHMWWQVASMNQ-UHFFFAOYSA-N 385621 US10287286, Example 38 Prolyl hydroxylase EGLN2 Homo sapiens 543 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385621&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 140850305 404854801 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772142 OCc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C14H10N4O/c15-7-10-1-3-12(4-2-10)13-5-11(8-19)6-14-16-9-17-18(13)14/h1-6,9,19H,8H2 ZZNRUONACXNPDC-UHFFFAOYSA-N 385624 US10287286, Example 39 Prolyl hydroxylase EGLN2 Homo sapiens 223 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385624&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540739 404854804 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772143 COC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C15H10N4O2/c1-21-15(20)12-6-13(19-14(7-12)17-9-18-19)11-4-2-10(8-16)3-5-11/h2-7,9H,1H3 PBWWNLBOKZZRNH-UHFFFAOYSA-N 385628 US10287286, Example 40 Prolyl hydroxylase EGLN2 Homo sapiens 323 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385628&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540616 404854808 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772144 OC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C14H8N4O2/c15-7-9-1-3-10(4-2-9)12-5-11(14(19)20)6-13-16-8-17-18(12)13/h1-6,8H,(H,19,20) NFWRDVSLYMEJFZ-UHFFFAOYSA-N 385632 US10287286, Example 41 Prolyl hydroxylase EGLN2 Homo sapiens 459 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385632&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540619 404854812 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772145 N#Cc1ccc(cc1)-c1cc(cc2ncnn12)C1CC1 InChI=1S/C16H12N4/c17-9-11-1-3-13(4-2-11)15-7-14(12-5-6-12)8-16-18-10-19-20(15)16/h1-4,7-8,10,12H,5-6H2 USVLWCODEVAHRR-UHFFFAOYSA-N 385634 US10287286, Example 42 Prolyl hydroxylase EGLN2 Homo sapiens 138 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385634&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540432 404854814 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772146 O=C(N1CCCC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C18H15N5O/c19-11-13-3-5-14(6-4-13)16-9-15(10-17-20-12-21-23(16)17)18(24)22-7-1-2-8-22/h3-6,9-10,12H,1-2,7-8H2 AIEXTHXNUBVWKC-UHFFFAOYSA-N 385635 4-[7-(pyrrolidine-1- carbonyl)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 43 Prolyl hydroxylase EGLN2 Homo sapiens 1840 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385635&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540301 404854815 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772147 COCCNC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H15N5O2/c1-24-7-6-19-17(23)14-8-15(22-16(9-14)20-11-21-22)13-4-2-12(10-18)3-5-13/h2-5,8-9,11H,6-7H2,1H3,(H,19,23) NGYRNGMPXPBBFT-UHFFFAOYSA-N 385636 5-(4-cyanophenyl)-N- (2-methoxyethyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 44 Prolyl hydroxylase EGLN2 Homo sapiens 1760 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385636&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540472 404854816 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772148 C[C@H]1CCCN1C(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C19H17N5O/c1-13-3-2-8-23(13)19(25)16-9-17(24-18(10-16)21-12-22-24)15-6-4-14(11-20)5-7-15/h4-7,9-10,12-13H,2-3,8H2,1H3/t13-/m0/s1 DDEHFJRZJDJUCA-ZDUSSCGKSA-N 385637 4-{7-[(2S)-2- methylpyrrolidine-1- carbonyl]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 45 Prolyl hydroxylase EGLN2 Homo sapiens 755 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385637&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540606 404854817 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772149 CC1CCN(C1)C(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C19H17N5O/c1-13-6-7-23(11-13)19(25)16-8-17(24-18(9-16)21-12-22-24)15-4-2-14(10-20)3-5-15/h2-5,8-9,12-13H,6-7,11H2,1H3 GYKWJYVNZNOYEO-UHFFFAOYSA-N 385638 4-[7-(3- methylpyrrolidine-1- carbonyl)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 46 Prolyl hydroxylase EGLN2 Homo sapiens 1949 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385638&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540582 404854818 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772150 COc1cccc(NC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C21H15N5O2/c1-28-18-4-2-3-17(11-18)25-21(27)16-9-19(26-20(10-16)23-13-24-26)15-7-5-14(12-22)6-8-15/h2-11,13H,1H3,(H,25,27) GRZVEPGDKJIDAY-UHFFFAOYSA-N 385639 5-(4-cyanophenyl)-N- (3-methoxyphenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 47 Prolyl hydroxylase EGLN2 Homo sapiens 470 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385639&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540629 404854819 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772151 Clc1cccc(CCNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C22H16ClN5O/c23-19-3-1-2-15(10-19)8-9-25-22(29)18-11-20(28-21(12-18)26-14-27-28)17-6-4-16(13-24)5-7-17/h1-7,10-12,14H,8-9H2,(H,25,29) JPIUCSSZYFZIEP-UHFFFAOYSA-N 385640 N-[2-(3- chlorophenyl)ethyl]-5- (4-cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 48 Prolyl hydroxylase EGLN2 Homo sapiens 206 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385640&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540296 404854820 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772152 Clc1ccc(CCNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)cc1 InChI=1S/C22H16ClN5O/c23-19-7-3-15(4-8-19)9-10-25-22(29)18-11-20(28-21(12-18)26-14-27-28)17-5-1-16(13-24)2-6-17/h1-8,11-12,14H,9-10H2,(H,25,29) VFAWPLDKMRFYHP-UHFFFAOYSA-N 385641 N-[2-(4- chlorophenyl)ethyl]-5- (4-cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 49 Prolyl hydroxylase EGLN2 Homo sapiens 366 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385641&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540345 404854821 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772153 COc1cccc(CCNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C23H19N5O2/c1-30-20-4-2-3-16(11-20)9-10-25-23(29)19-12-21(28-22(13-19)26-15-27-28)18-7-5-17(14-24)6-8-18/h2-8,11-13,15H,9-10H2,1H3,(H,25,29) BOFLQVCHXQZMPZ-UHFFFAOYSA-N 385642 5-(4-cyanophenyl)-N- [2-(3- methoxyphenyl)ethyl]- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 50 Prolyl hydroxylase EGLN2 Homo sapiens 927 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385642&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540626 404854822 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772154 Clc1cccc(NC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C20H12ClN5O/c21-16-2-1-3-17(10-16)25-20(27)15-8-18(26-19(9-15)23-12-24-26)14-6-4-13(11-22)5-7-14/h1-10,12H,(H,25,27) WUWBMHKGIUDZGD-UHFFFAOYSA-N 385643 N-(3-chlorophenyl)-5- (4-cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 51 Prolyl hydroxylase EGLN2 Homo sapiens 978 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385643&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540693 404854823 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772155 Clc1ccc(NC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)cc1 InChI=1S/C20H12ClN5O/c21-16-5-7-17(8-6-16)25-20(27)15-9-18(26-19(10-15)23-12-24-26)14-3-1-13(11-22)2-4-14/h1-10,12H,(H,25,27) ZGDGTIVBKOFQBD-UHFFFAOYSA-N 385644 N-(4-chlorophenyl)-5- (4-cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 52 Prolyl hydroxylase EGLN2 Homo sapiens 531 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385644&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540694 404854824 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772156 Cc1ccc(NC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)nn1 InChI=1S/C19H13N7O/c1-12-2-7-17(25-24-12)23-19(27)15-8-16(26-18(9-15)21-11-22-26)14-5-3-13(10-20)4-6-14/h2-9,11H,1H3,(H,23,25,27) IZCYSBVSDGPVRK-UHFFFAOYSA-N 385645 5-(4-cyanophenyl)-N- (6-methylpyridazin-3- yl)-[1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 53 Prolyl hydroxylase EGLN2 Homo sapiens 387 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385645&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540556 404854825 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772157 Cc1ncc(NC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)cn1 InChI=1S/C19H13N7O/c1-12-21-9-16(10-22-12)25-19(27)15-6-17(26-18(7-15)23-11-24-26)14-4-2-13(8-20)3-5-14/h2-7,9-11H,1H3,(H,25,27) QHLMNUKMRIYUAW-UHFFFAOYSA-N 385646 5-(4-cyanophenyl)-N- (2-methylpyrimidin-5- yl)-[1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 54 Prolyl hydroxylase EGLN2 Homo sapiens 730 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385646&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540416 404854826 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772158 Clc1cccc(CNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C21H14ClN5O/c22-18-3-1-2-15(8-18)12-24-21(28)17-9-19(27-20(10-17)25-13-26-27)16-6-4-14(11-23)5-7-16/h1-10,13H,12H2,(H,24,28) JJYJJVFWDYJUSP-UHFFFAOYSA-N 385647 N-[(3- chlorophenyl)methyl]- 5-(4-cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 55 Prolyl hydroxylase EGLN2 Homo sapiens 307 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385647&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540329 404854827 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772159 Clc1ccc(CNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)cc1 InChI=1S/C21H14ClN5O/c22-18-7-3-15(4-8-18)12-24-21(28)17-9-19(27-20(10-17)25-13-26-27)16-5-1-14(11-23)2-6-16/h1-10,13H,12H2,(H,24,28) NDSAZYCNIBPPHW-UHFFFAOYSA-N 385648 N-[(4- chlorophenyl)methyl]- 5-(4-cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 56 Prolyl hydroxylase EGLN2 Homo sapiens 167 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385648&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540398 404854828 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772160 COc1cccc(CNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C22H17N5O2/c1-29-19-4-2-3-16(9-19)13-24-22(28)18-10-20(27-21(11-18)25-14-26-27)17-7-5-15(12-23)6-8-17/h2-11,14H,13H2,1H3,(H,24,28) ICUPEDVGLRAKAS-UHFFFAOYSA-N 385649 5-(4-cyanophenyl)-N- [(3-methoxyphenyl) methyl]- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 57 Prolyl hydroxylase EGLN2 Homo sapiens 445 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385649&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540280 404854829 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772161 NC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C14H9N5O/c15-7-9-1-3-10(4-2-9)12-5-11(14(16)20)6-13-17-8-18-19(12)13/h1-6,8H,(H2,16,20) IPSCFFIGHRZVOS-UHFFFAOYSA-N 385650 5-(4-cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 58 Prolyl hydroxylase EGLN2 Homo sapiens 145 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385650&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540343 404854830 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772162 CNC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C15H11N5O/c1-17-15(21)12-6-13(20-14(7-12)18-9-19-20)11-4-2-10(8-16)3-5-11/h2-7,9H,1H3,(H,17,21) WCCNPIWYHHHVPG-UHFFFAOYSA-N 385651 5-(4-cyanophenyl)-N- methyl- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 59 Prolyl hydroxylase EGLN2 Homo sapiens 269 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385651&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540339 404854831 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772163 CCCCNC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C18H17N5O/c1-2-3-8-20-18(24)15-9-16(23-17(10-15)21-12-22-23)14-6-4-13(11-19)5-7-14/h4-7,9-10,12H,2-3,8H2,1H3,(H,20,24) ZUGXFJNOSHGEMY-UHFFFAOYSA-N 385652 N-butyl-5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 60 Prolyl hydroxylase EGLN2 Homo sapiens 377 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385652&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540589 404854832 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772164 Cn1cnc(CNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C19H15N7O/c1-25-10-16(23-12-25)9-21-19(27)15-6-17(26-18(7-15)22-11-24-26)14-4-2-13(8-20)3-5-14/h2-7,10-12H,9H2,1H3,(H,21,27) ROAIFRXLTQHIHL-UHFFFAOYSA-N 385653 5-(4-cyanophenyl)-N- [(1-methyl-1H- imidazol-4- yl)methyl]- [1,2,4]triazolo[1,5- a]pyridine-7-::US10287286, Example 61 Prolyl hydroxylase EGLN2 Homo sapiens 392 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385653&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540335 404854833 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772165 Cn1cc(CNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)cn1 InChI=1S/C19H15N7O/c1-25-11-14(10-23-25)9-21-19(27)16-6-17(26-18(7-16)22-12-24-26)15-4-2-13(8-20)3-5-15/h2-7,10-12H,9H2,1H3,(H,21,27) IURSGDYCPOLPTG-UHFFFAOYSA-N 385654 5-(4-cyanophenyl)-N- [(1-methyl-1H- pyrazol-4-yl)methyl]- [1,2,4]triazolo]1,5- a]pyridine-7- carboxamide::US10287286, Example 62 Prolyl hydroxylase EGLN2 Homo sapiens 490 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385654&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540379 404854834 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772166 CC(C)(C)OC(=O)N1CC(CNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)C1 InChI=1S/C23H24N6O3/c1-23(2,3)32-22(31)28-12-16(13-28)11-25-21(30)18-8-19(29-20(9-18)26-14-27-29)17-6-4-15(10-24)5-7-17/h4-9,14,16H,11-13H2,1-3H3,(H,25,30) OZDDETGHBHNVSA-UHFFFAOYSA-N 385655 US10287286, Example 63::tert-butyl 3-({[5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]formamido} methyl)azetidine-1- carboxylate Prolyl hydroxylase EGLN2 Homo sapiens 714 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385655&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328369 404854835 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772167 O=C(NCCN1CCOCC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C20H20N6O2/c21-13-15-1-3-16(4-2-15)18-11-17(12-19-23-14-24-26(18)19)20(27)22-5-6-25-7-9-28-10-8-25/h1-4,11-12,14H,5-10H2,(H,22,27) IXGZRTLTOKJARN-UHFFFAOYSA-N 385656 5-(4-cyanophenyl)-N- [2-(morpholin-4-yl) ethyl]- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 64 Prolyl hydroxylase EGLN2 Homo sapiens 669 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385656&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540294 404854836 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772168 CN1CCN(CCNC(=O)c2cc(-c3ccc(cc3)C#N)n3ncnc3c2)CC1 InChI=1S/C21H23N7O/c1-26-8-10-27(11-9-26)7-6-23-21(29)18-12-19(28-20(13-18)24-15-25-28)17-4-2-16(14-22)3-5-17/h2-5,12-13,15H,6-11H2,1H3,(H,23,29) QHASUZQZHCPRHM-UHFFFAOYSA-N 385657 5-(4-cyanophenyl)-N- [2-(4- methylpiperazin-1- yl)ethyl]- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 65 Prolyl hydroxylase EGLN2 Homo sapiens 551 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385657&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540649 404854837 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772169 CC(C)NC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H15N5O/c1-11(2)21-17(23)14-7-15(22-16(8-14)19-10-20-22)13-5-3-12(9-18)4-6-13/h3-8,10-11H,1-2H3,(H,21,23) XEHZSSQNQZTTAC-UHFFFAOYSA-N 385658 5-(4-cyanophenyl)-N- (propan-2-yl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 66 Prolyl hydroxylase EGLN2 Homo sapiens 613 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385658&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540686 404854838 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772170 O=C(NCC1CC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C18H15N5O/c19-9-12-3-5-14(6-4-12)16-7-15(8-17-21-11-22-23(16)17)18(24)20-10-13-1-2-13/h3-8,11,13H,1-2,10H2,(H,20,24) PNZVJNFRTDGQNR-UHFFFAOYSA-N 385659 5-(4-cyanophenyl)-N- (cyclopropylmethyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 67 Prolyl hydroxylase EGLN2 Homo sapiens 103 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385659&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540315 404854839 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772171 O=C(NC1COC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H13N5O2/c18-7-11-1-3-12(4-2-11)15-5-13(6-16-19-10-20-22(15)16)17(23)21-14-8-24-9-14/h1-6,10,14H,8-9H2,(H,21,23) GQZLLNMBCOFNNK-UHFFFAOYSA-N 385660 5-(4-cyanophenyl)-N- (oxetan-3-yl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 68 Prolyl hydroxylase EGLN2 Homo sapiens 1885 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385660&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540571 404854840 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772172 O=C(NCC1COC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C18H15N5O2/c19-7-12-1-3-14(4-2-12)16-5-15(6-17-21-11-22-23(16)17)18(24)20-8-13-9-25-10-13/h1-6,11,13H,8-10H2,(H,20,24) LPGIHRUBSJSGGJ-UHFFFAOYSA-N 385661 5-(4-cyanophenyl)-N- (oxetan-3-ylmethyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 69 Prolyl hydroxylase EGLN2 Homo sapiens 1114 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385661&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540743 404854841 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772173 CN1CC(C1)NC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C18H16N6O/c1-23-9-15(10-23)22-18(25)14-6-16(24-17(7-14)20-11-21-24)13-4-2-12(8-19)3-5-13/h2-7,11,15H,9-10H2,1H3,(H,22,25) HNRQYSVIXVIEJZ-UHFFFAOYSA-N 385662 5-(4-cyanophenyl)-N- (1-methylazetidin-3- yl)-[1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 70 Prolyl hydroxylase EGLN2 Homo sapiens 607 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385662&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540467 404854842 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772174 OCCNC(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C16H13N5O2/c17-9-11-1-3-12(4-2-11)14-7-13(16(23)18-5-6-22)8-15-19-10-20-21(14)15/h1-4,7-8,10,22H,5-6H2,(H,18,23) FPYFECNOOPIONX-UHFFFAOYSA-N 385663 5-(4-cyanophenyl)-N- (2-hydroxyethyl)- [1,2,4]triazolo[1,5- a]pyridine-7- carboxamide::US10287286, Example 71 Prolyl hydroxylase EGLN2 Homo sapiens 904 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385663&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540756 404854843 C04080 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772175 CN(C)CCNc1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C16H17N7/c1-22(2)8-7-18-15-9-14(23-16(21-15)19-11-20-23)13-5-3-12(10-17)4-6-13/h3-6,9,11H,7-8H2,1-2H3,(H,18,19,20,21) FATVGAYGSOOCKR-UHFFFAOYSA-N 385664 4-(5-{[2- (dimethylamino) ethyl]amino}- [1,2,4]triazolo [1,5-a]pyrimidin-7- yl)benzonitrile::US10287286, Example 72 Prolyl hydroxylase EGLN2 Homo sapiens 5086 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385664&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540621 404854844 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772176 CN(C)C1CCN(C1)c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C18H19N7/c1-23(2)15-7-8-24(11-15)17-9-16(25-18(22-17)20-12-21-25)14-5-3-13(10-19)4-6-14/h3-6,9,12,15H,7-8,11H2,1-2H3 YASMBVRKQVNAQB-UHFFFAOYSA-N 385665 4-{5-[3- (dimethylamino) pyrrolidin-1-yl]- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl}benzonitrile::US10287286, Example 73 Prolyl hydroxylase EGLN2 Homo sapiens 5436 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385665&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328392 404854845 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772177 CNC(=O)C1CCCN1c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C18H17N7O/c1-20-17(26)14-3-2-8-24(14)16-9-15(25-18(23-16)21-11-22-25)13-6-4-12(10-19)5-7-13/h4-7,9,11,14H,2-3,8H2,1H3,(H,20,26) ISBSYTQNXHPLII-UHFFFAOYSA-N 385666 1-[7-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyrimidin-5-yl]-N- methylpyrrolidine-2- carboxamide::US10287286, Example 74 Prolyl hydroxylase EGLN2 Homo sapiens 184 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385666&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540595 404854846 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772178 N#Cc1ccc(cc1)-c1cc(nc2ncnn12)N1CCC[C@H]1CN1CCCC1 InChI=1S/C21H23N7/c22-13-16-5-7-17(8-6-16)19-12-20(25-21-23-15-24-28(19)21)27-11-3-4-18(27)14-26-9-1-2-10-26/h5-8,12,15,18H,1-4,9-11,14H2/t18-/m0/s1 ZSLALNOUQFVFEF-SFHVURJKSA-N 385667 4-{5-[(2S)-2- (pyrrolidin-1- ylmethyl) pyrrolidin-1-yl]- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl}benzonitrile::US10287286, Example 75 Prolyl hydroxylase EGLN2 Homo sapiens 2158 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385667&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328386 404854847 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772179 N#Cc1ccc(cc1)-c1cc(nc2ncnn12)N1CCCC(C1)N1CCCC1 InChI=1S/C21H23N7/c22-13-16-5-7-17(8-6-16)19-12-20(25-21-23-15-24-28(19)21)27-11-3-4-18(14-27)26-9-1-2-10-26/h5-8,12,15,18H,1-4,9-11,14H2 CPEUGAPFGVNLBR-UHFFFAOYSA-N 385668 4-{5-[3-(pyrrolidin- 1-yl)piperidin-1-yl]- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl}benzonitrile::US10287286, Example 76 Prolyl hydroxylase EGLN2 Homo sapiens 969 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385668&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540300 404854848 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772180 CN1CCC(CC1)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C18H19N7/c1-24-8-6-15(7-9-24)22-17-10-16(25-18(23-17)20-12-21-25)14-4-2-13(11-19)3-5-14/h2-5,10,12,15H,6-9H2,1H3,(H,20,21,22,23) QATJNFFTJCWJPO-UHFFFAOYSA-N 385669 4-{5-[(1- methylpiperidin- 4-yl)amino]- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl}benzonitrile::US10287286, Example 77 Prolyl hydroxylase EGLN2 Homo sapiens 2043 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385669&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328452 404854849 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772181 CN1CCCC(C1)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C18H19N7/c1-24-8-2-3-15(11-24)22-17-9-16(25-18(23-17)20-12-21-25)14-6-4-13(10-19)5-7-14/h4-7,9,12,15H,2-3,8,11H2,1H3,(H,20,21,22,23) UITNBPPHMUHXNX-UHFFFAOYSA-N 385670 4-{5-[(1- methylpiperidin- 3-yl)amino]- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl}benzonitrile::US10287286, Example 78 Prolyl hydroxylase EGLN2 Homo sapiens 1833 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385670&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328453 404854850 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772182 CC(=O)N1CCCC(C1)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C19H19N7O/c1-13(27)25-8-2-3-16(11-25)23-18-9-17(26-19(24-18)21-12-22-26)15-6-4-14(10-20)5-7-15/h4-7,9,12,16H,2-3,8,11H2,1H3,(H,21,22,23,24) ANXOXPYLOKXRDN-UHFFFAOYSA-N 385671 4-{5-[(1- acetylpiperidin- 3-yl)amino]- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl}benzonitrile::US10287286, Example 79 Prolyl hydroxylase EGLN2 Homo sapiens 275 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385671&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540540 404854851 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772183 CN1CCC(CNc2cc(-c3ccc(cc3)C#N)n3ncnc3n2)CC1 InChI=1S/C19H21N7/c1-25-8-6-15(7-9-25)12-21-18-10-17(26-19(24-18)22-13-23-26)16-4-2-14(11-20)3-5-16/h2-5,10,13,15H,6-9,12H2,1H3,(H,21,22,23,24) RLBACSDULXGRAX-UHFFFAOYSA-N 385672 4-(5-{[(1- methylpiperidin-4- yl)methyl]amino}- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)benzonitrile::US10287286, Example 80 Prolyl hydroxylase EGLN2 Homo sapiens 3000 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385672&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540299 404854852 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772184 O=C1CCCN1CCNc1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C18H17N7O/c19-11-13-3-5-14(6-4-13)15-10-16(23-18-21-12-22-25(15)18)20-7-9-24-8-1-2-17(24)26/h3-6,10,12H,1-2,7-9H2,(H,20,21,22,23) BUWDIWNTAXRQNN-UHFFFAOYSA-N 385673 4-(5-{[2-(2- oxopyrrolidin-1- yl)ethyl]amino}- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)benzonitrile::US10287286, Example 81 Prolyl hydroxylase EGLN2 Homo sapiens 884 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385673&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540344 404854853 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772185 CN(C)c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C14H12N6/c1-19(2)13-7-12(20-14(18-13)16-9-17-20)11-5-3-10(8-15)4-6-11/h3-7,9H,1-2H3 HPAGEUKPYIALBE-UHFFFAOYSA-N 385674 4-[5- (dimethylamino)- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl]benzonitrile::US10287286, Example 82 Prolyl hydroxylase EGLN2 Homo sapiens 11.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385674&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328424 404854854 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772186 N#Cc1ccc(cc1)-c1cc(nc2ncnn12)N1CCCC1 InChI=1S/C16H14N6/c17-10-12-3-5-13(6-4-12)14-9-15(21-7-1-2-8-21)20-16-18-11-19-22(14)16/h3-6,9,11H,1-2,7-8H2 RAZKIIRGUKVTKW-UHFFFAOYSA-N 385675 4-[5-(pyrrolidin-1- yl)-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl]benzonitrile::US10287286, Example 83 Prolyl hydroxylase EGLN2 Homo sapiens 406 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385675&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328400 404854855 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772187 N#Cc1ccc(cc1)-c1cc(NCC2CC2)nc2ncnn12 InChI=1S/C16H14N6/c17-8-11-3-5-13(6-4-11)14-7-15(18-9-12-1-2-12)21-16-19-10-20-22(14)16/h3-7,10,12H,1-2,9H2,(H,18,19,20,21) KCKPSLUURQVERX-UHFFFAOYSA-N 385676 4-{5- [(cyclopropylmethyl) amino]-[1,2,4] triazolo [1,5-a]pyrimidin-7- yl}benzonitrile::US10287286, Example 84 Prolyl hydroxylase EGLN2 Homo sapiens 5.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385676&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328418 404854856 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772188 CN(CC1CC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C17H16N6/c1-22(10-13-2-3-13)16-8-15(23-17(21-16)19-11-20-23)14-6-4-12(9-18)5-7-14/h4-8,11,13H,2-3,10H2,1H3 BURXLKMOIPHNPW-UHFFFAOYSA-N 385677 4-{5- [(cyclopropylmethyl) (methyl)amino]- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl}benzonitrile::US10287286, Example 85 Prolyl hydroxylase EGLN2 Homo sapiens 164 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385677&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328413 404854857 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772189 N#Cc1ccc(cc1)-c1cc(NCCN2CCCC2)nc2ncnn12 InChI=1S/C18H19N7/c19-12-14-3-5-15(6-4-14)16-11-17(23-18-21-13-22-25(16)18)20-7-10-24-8-1-2-9-24/h3-6,11,13H,1-2,7-10H2,(H,20,21,22,23) UOQCBMDBWIQVKB-UHFFFAOYSA-N 385678 4-(5-{[2-(pyrrolidin- 1-yl)ethyl]amino}- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)benzonitrile::US10287286, Example 86 Prolyl hydroxylase EGLN2 Homo sapiens 2108 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385678&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328423 404854858 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772190 CN(C)CCN(C)c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C17H19N7/c1-22(2)8-9-23(3)16-10-15(24-17(21-16)19-12-20-24)14-6-4-13(11-18)5-7-14/h4-7,10,12H,8-9H2,1-3H3 IUMAZEKBIQWFHO-UHFFFAOYSA-N 385679 4-(5-{[2- (dimethylamino) ethyl](methyl)amino [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)benzonitrile::US10287286, Example 87 Prolyl hydroxylase EGLN2 Homo sapiens 119 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385679&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328494 404854859 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772191 CN(C)CCCNc1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C17H19N7/c1-23(2)9-3-8-19-16-10-15(24-17(22-16)20-12-21-24)14-6-4-13(11-18)5-7-14/h4-7,10,12H,3,8-9H2,1-2H3,(H,19,20,21,22) JUIXYUJHCFKWFY-UHFFFAOYSA-N 385680 4-(5-{[3- (dimethylamino) propyl]amino}- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)benzonitrile::US10287286, Example 88 Prolyl hydroxylase EGLN2 Homo sapiens 29.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385680&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540698 404854860 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772192 CC1CCCN1c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C17H16N6/c1-12-3-2-8-22(12)16-9-15(23-17(21-16)19-11-20-23)14-6-4-13(10-18)5-7-14/h4-7,9,11-12H,2-3,8H2,1H3 ONWQIEYWGVOTBF-UHFFFAOYSA-N 385681 4-[5-(2- methylpyrrolidin- 1-yl)-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl]benzonitrile::US10287286, Example 89 Prolyl hydroxylase EGLN2 Homo sapiens 360 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385681&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540562 404854861 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772193 CC1CCN(C1)c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C17H16N6/c1-12-6-7-22(10-12)16-8-15(23-17(21-16)19-11-20-23)14-4-2-13(9-18)3-5-14/h2-5,8,11-12H,6-7,10H2,1H3 AISUXZNJLUKPST-UHFFFAOYSA-N 385682 4-[5-(3- methylpyrrolidin- 1-yl)-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl]benzonitrile::US10287286, Example 90 Prolyl hydroxylase EGLN2 Homo sapiens 574 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385682&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328389 404854862 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772194 CC1CCC(C)N1c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C18H18N6/c1-12-3-4-13(2)23(12)17-9-16(24-18(22-17)20-11-21-24)15-7-5-14(10-19)6-8-15/h5-9,11-13H,3-4H2,1-2H3 UVYMEFOGGRNGCX-UHFFFAOYSA-N 385683 4-[5-(2,5- dimethylpyrrolidin- 1-yl)-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl]benzonitrile::US10287286, Example 91 Prolyl hydroxylase EGLN2 Homo sapiens 2448 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385683&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328430 404854863 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772195 CC1(C)CCN(C1)c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C18H18N6/c1-18(2)7-8-23(11-18)16-9-15(24-17(22-16)20-12-21-24)14-5-3-13(10-19)4-6-14/h3-6,9,12H,7-8,11H2,1-2H3 HAQRHQMXCWYWPC-UHFFFAOYSA-N 385684 4-[5-(3,3- dimethylpyrrolidin- 1-yl)-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl]benzonitrile::US10287286, Example 92 Prolyl hydroxylase EGLN2 Homo sapiens 792 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385684&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328374 404854864 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772196 N#Cc1ccc(cc1)-c1cc(nc2ncnn12)N1CCCC1C1CC1 InChI=1S/C19H18N6/c20-11-13-3-5-15(6-4-13)17-10-18(23-19-21-12-22-25(17)19)24-9-1-2-16(24)14-7-8-14/h3-6,10,12,14,16H,1-2,7-9H2 JSEUHXHNNAFTFL-UHFFFAOYSA-N 385685 4-[5-(2- cyclopropylpyrrolidin- 1-yl)-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl]benzonitrile::US10287286, Example 93 Prolyl hydroxylase EGLN2 Homo sapiens 129 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385685&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328434 404854865 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772197 CC(C)CC1CCCN1c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C20H22N6/c1-14(2)10-17-4-3-9-25(17)19-11-18(26-20(24-19)22-13-23-26)16-7-5-15(12-21)6-8-16/h5-8,11,13-14,17H,3-4,9-10H2,1-2H3 LGYAFWDOARMYIT-UHFFFAOYSA-N 385686 4-{5-[2-(2- methylpropyl) pyrrolidin- 1-yl]-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl}benzonitrile::US10287286, Example 94 Prolyl hydroxylase EGLN2 Homo sapiens 238 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385686&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328401 404854866 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772198 CC(C)CCNc1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C17H18N6/c1-12(2)7-8-19-16-9-15(23-17(22-16)20-11-21-23)14-5-3-13(10-18)4-6-14/h3-6,9,11-12H,7-8H2,1-2H3,(H,19,20,21,22) ZGKNNTYIEQGHAX-UHFFFAOYSA-N 385687 4-{5-[(3- methylbutyl)amino]- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl}benzonitrile::US10287286, Example 95 Prolyl hydroxylase EGLN2 Homo sapiens 61.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385687&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328417 404854867 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772199 N#Cc1ccc(cc1)-c1cc(NC2CC2)nc2ncnn12 InChI=1S/C15H12N6/c16-8-10-1-3-11(4-2-10)13-7-14(19-12-5-6-12)20-15-17-9-18-21(13)15/h1-4,7,9,12H,5-6H2,(H,17,18,19,20) HROMSNWTIDLGSP-UHFFFAOYSA-N 385688 4-[5- (cyclopropylamino)- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl]benzonitrile::US10287286, Example 96 Prolyl hydroxylase EGLN2 Homo sapiens 32.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385688&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540746 404854868 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772200 CC(C)CC1CCN(C1)c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C20H22N6/c1-14(2)9-16-7-8-25(12-16)19-10-18(26-20(24-19)22-13-23-26)17-5-3-15(11-21)4-6-17/h3-6,10,13-14,16H,7-9,12H2,1-2H3 QAUJNZGVGPBVIV-UHFFFAOYSA-N 385689 4-{5-[3-(2- methylpropyl) pyrrolidin- 1-yl]-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl}benzonitrile::US10287286, Example 97 Prolyl hydroxylase EGLN2 Homo sapiens 115 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385689&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540303 404854869 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772201 N#Cc1ccc(cc1)-c1cc(nc2ncnn12)N1CCC2(CCC2)CC1 InChI=1S/C20H20N6/c21-13-15-2-4-16(5-3-15)17-12-18(24-19-22-14-23-26(17)19)25-10-8-20(9-11-25)6-1-7-20/h2-5,12,14H,1,6-11H2 LVRGKCYOWJHNES-UHFFFAOYSA-N 385690 4-(5-{7- azaspiro[3.5]nonan-7- yl}-[1,2,4]triazolo[1,5- a]pyrimidin-7- yl)benzonitrile::US10287286, Example 98 Prolyl hydroxylase EGLN2 Homo sapiens 427 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385690&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540612 404854870 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772202 CN(C1CC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C16H14N6/c1-21(13-6-7-13)15-8-14(22-16(20-15)18-10-19-22)12-4-2-11(9-17)3-5-12/h2-5,8,10,13H,6-7H2,1H3 BMIUKFHAPOZEMP-UHFFFAOYSA-N 385691 4-{5- [cyclopropyl(methyl) amino]-[1,2,4]triazolo [1,5-a]pyrimidin-7- yl}benzonitrile::US10287286, Example 99 Prolyl hydroxylase EGLN2 Homo sapiens 435 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385691&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328427 404854871 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772203 Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C13H9N5/c14-7-9-1-3-10(4-2-9)12-5-11(15)6-13-16-8-17-18(12)13/h1-6,8H,15H2 ZKHPNASIRYLBNH-UHFFFAOYSA-N 50239889 CHEMBL4072842::US10287286, Example 100 Prolyl hydroxylase EGLN2 Homo sapiens 13.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239889&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448987 85715283 CHEMBL4072842 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772204 N#Cc1ccc(cc1)-c1cc(NCC2CC2)cc2ncnn12 InChI=1S/C17H15N5/c18-9-12-3-5-14(6-4-12)16-7-15(19-10-13-1-2-13)8-17-20-11-21-22(16)17/h3-8,11,13,19H,1-2,10H2 HAYKWHIVYOQGOH-UHFFFAOYSA-N 385693 4-{7- [(cyclopropyl- methyl) amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 101 Prolyl hydroxylase EGLN2 Homo sapiens 9.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385693&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540673 404854873 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772205 COCCNc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C16H15N5O/c1-22-7-6-18-14-8-15(21-16(9-14)19-11-20-21)13-4-2-12(10-17)3-5-13/h2-5,8-9,11,18H,6-7H2,1H3 WGGZDJUYALKJIH-UHFFFAOYSA-N 385694 4-{7-(2- methoxyethyl) amino}- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 102 Prolyl hydroxylase EGLN2 Homo sapiens 34.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385694&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540575 404854874 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772206 CCNc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C15H13N5/c1-2-17-13-7-14(20-15(8-13)18-10-19-20)12-5-3-11(9-16)4-6-12/h3-8,10,17H,2H2,1H3 ROJZYGFAQBIEGG-UHFFFAOYSA-N 50239888 CHEMBL4094292::US10287286, Example 103 Prolyl hydroxylase EGLN2 Homo sapiens 25.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239888&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 11555886 85715656 CHEMBL4094292 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772207 N#Cc1ccc(cc1)-c1cc(NCC2CCOCC2)cc2ncnn12 InChI=1S/C19H19N5O/c20-11-14-1-3-16(4-2-14)18-9-17(10-19-22-13-23-24(18)19)21-12-15-5-7-25-8-6-15/h1-4,9-10,13,15,21H,5-8,12H2 PDUUXICHUULHEW-UHFFFAOYSA-N 385697 4-{7-[(oxan-4- ylmethyl)amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 104 Prolyl hydroxylase EGLN2 Homo sapiens 37.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385697&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540423 404854877 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772208 N#Cc1ccc(cc1)-c1cc(NCC2CCOC2)cc2ncnn12 InChI=1S/C18H17N5O/c19-9-13-1-3-15(4-2-13)17-7-16(8-18-21-12-22-23(17)18)20-10-14-5-6-24-11-14/h1-4,7-8,12,14,20H,5-6,10-11H2 GFOZTDWNJGZQIA-UHFFFAOYSA-N 385698 4-{7-[(oxolan-3- ylmethyl)amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 105 Prolyl hydroxylase EGLN2 Homo sapiens 25.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385698&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540396 404854878 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772209 FC(F)CNc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C15H11F2N5/c16-14(17)8-19-12-5-13(22-15(6-12)20-9-21-22)11-3-1-10(7-18)2-4-11/h1-6,9,14,19H,8H2 RVSQXEPIPJUJSE-UHFFFAOYSA-N 385700 4-{7-[(2,2- difluoroethyl) amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 106 Prolyl hydroxylase EGLN2 Homo sapiens 10.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385700&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328426 404854880 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772210 N#Cc1ccc(cc1)-c1cc(NCC2COC2)cc2ncnn12 InChI=1S/C17H15N5O/c18-7-12-1-3-14(4-2-12)16-5-15(19-8-13-9-23-10-13)6-17-20-11-21-22(16)17/h1-6,11,13,19H,8-10H2 OKKZJSAGVOEQNC-UHFFFAOYSA-N 385701 4-{7-[(oxetan-3- ylmethyl)amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 107 Prolyl hydroxylase EGLN2 Homo sapiens 5.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385701&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540340 404854881 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772211 FC(F)(F)CCNc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C16H12F3N5/c17-16(18,19)5-6-21-13-7-14(24-15(8-13)22-10-23-24)12-3-1-11(9-20)2-4-12/h1-4,7-8,10,21H,5-6H2 JHTDBBSCILMZHF-UHFFFAOYSA-N 385702 4-{7-[(3,3,3- trifluoropropyl) amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 108 Prolyl hydroxylase EGLN2 Homo sapiens 9.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385702&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540555 404854882 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772212 N#Cc1ccc(cc1)-c1cc(NCCCN2CCOCC2)cc2ncnn12 InChI=1S/C20H22N6O/c21-14-16-2-4-17(5-3-16)19-12-18(13-20-23-15-24-26(19)20)22-6-1-7-25-8-10-27-11-9-25/h2-5,12-13,15,22H,1,6-11H2 SQQOOTPITZITFP-UHFFFAOYSA-N 385703 4-(7-{[3-(morpholin- 4-yl)propyl]amino}- [1,2,4]triazolo[1,5- a]pyridin-5- yl)benzonitrile::US10287286, Example 109 Prolyl hydroxylase EGLN2 Homo sapiens 77.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385703&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540408 404854883 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772213 CC(C)(O)CNc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H17N5O/c1-17(2,23)10-19-14-7-15(22-16(8-14)20-11-21-22)13-5-3-12(9-18)4-6-13/h3-8,11,19,23H,10H2,1-2H3 QWPUYQJBBNNHQJ-UHFFFAOYSA-N 385704 4-{7-[(2-hydroxy- 2-methylpropyl) amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 110 Prolyl hydroxylase EGLN2 Homo sapiens 166 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385704&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540646 404854884 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772214 COCCCNc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H17N5O/c1-23-8-2-7-19-15-9-16(22-17(10-15)20-12-21-22)14-5-3-13(11-18)4-6-14/h3-6,9-10,12,19H,2,7-8H2,1H3 AKEYSUXDCRNKMQ-UHFFFAOYSA-N 385705 4-{7-[(3- methoxypropyl) amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 111 Prolyl hydroxylase EGLN2 Homo sapiens 247 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385705&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540651 404854885 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772215 N#Cc1ccc(cc1)-c1cc(NCC2CCCO2)cc2ncnn12 InChI=1S/C18H17N5O/c19-10-13-3-5-14(6-4-13)17-8-15(9-18-21-12-22-23(17)18)20-11-16-2-1-7-24-16/h3-6,8-9,12,16,20H,1-2,7,11H2 ZZTSLNIRICVWLB-UHFFFAOYSA-N 385706 4-{7-[(oxolan-2- ylmethyl)amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 112 Prolyl hydroxylase EGLN2 Homo sapiens 20.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385706&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540292 404854886 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772216 CN(C)CCNc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H18N6/c1-22(2)8-7-19-15-9-16(23-17(10-15)20-12-21-23)14-5-3-13(11-18)4-6-14/h3-6,9-10,12,19H,7-8H2,1-2H3 GEYIFHGJFNVOIZ-UHFFFAOYSA-N 385707 4-(7-{[2- (dimethylamino) ethyl]amino}- [1,2,4]triazolo[1,5- a]pyridin-5- yl)benzonitrile::US10287286, Example 113 Prolyl hydroxylase EGLN2 Homo sapiens 8.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385707&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540719 404854887 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772217 N#Cc1ccc(cc1)-c1cc(NCc2ccccc2)cc2ncnn12 InChI=1S/C20H15N5/c21-12-15-6-8-17(9-7-15)19-10-18(11-20-23-14-24-25(19)20)22-13-16-4-2-1-3-5-16/h1-11,14,22H,13H2 ZEMUMFOIIYWVQZ-UHFFFAOYSA-N 385708 4-[7-(benzylamino)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 114 Prolyl hydroxylase EGLN2 Homo sapiens 33.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385708&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540324 404854888 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772218 Fc1ccccc1CNc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C20H14FN5/c21-18-4-2-1-3-16(18)12-23-17-9-19(26-20(10-17)24-13-25-26)15-7-5-14(11-22)6-8-15/h1-10,13,23H,12H2 OESRLBUJEOVQFO-UHFFFAOYSA-N 385709 4-(7-{[(2- fluorophenyl) methyl]amino}- [1,2,4]triazolo[1,5- a]pyridin-5- yl)benzonitrile::US10287286, Example 115 Prolyl hydroxylase EGLN2 Homo sapiens 13.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385709&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540653 404854889 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772219 Fc1cccc(CNc2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C20H14FN5/c21-17-3-1-2-15(8-17)12-23-18-9-19(26-20(10-18)24-13-25-26)16-6-4-14(11-22)5-7-16/h1-10,13,23H,12H2 DUKBFVQAMAGALG-UHFFFAOYSA-N 385710 4-(7-{[(3- fluorophenyl) methyl]amino}- [1,2,4]triazolo[1,5- a]pyridin-5- yl)benzonitrile::US10287286, Example 116 Prolyl hydroxylase EGLN2 Homo sapiens 29.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385710&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540279 404854890 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772220 Fc1ccc(CNc2cc(-c3ccc(cc3)C#N)n3ncnc3c2)cc1 InChI=1S/C20H14FN5/c21-17-7-3-15(4-8-17)12-23-18-9-19(26-20(10-18)24-13-25-26)16-5-1-14(11-22)2-6-16/h1-10,13,23H,12H2 DDBNRFRBPGDKLB-UHFFFAOYSA-N 385711 4-(7-{[(4- fluorophenyl) methyl]amino}- [1,2,4]triazolo[1,5- a]pyridin-5- yl)benzonitrile::US10287286, Example 117 Prolyl hydroxylase EGLN2 Homo sapiens 5.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385711&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540316 404854891 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772221 N#Cc1ccc(cc1)-c1cc(OCC2CC2)cc2ncnn12 InChI=1S/C17H14N4O/c18-9-12-3-5-14(6-4-12)16-7-15(22-10-13-1-2-13)8-17-19-11-20-21(16)17/h3-8,11,13H,1-2,10H2 JCSJIJVKUYLANF-UHFFFAOYSA-N 385712 4-[7- (cyclopropyl- methoxy)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 118 Prolyl hydroxylase EGLN2 Homo sapiens 54.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385712&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540658 404854892 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772222 N#Cc1ccc(cc1)-c1cc(OCc2ccccc2)cc2ncnn12 InChI=1S/C20H14N4O/c21-12-15-6-8-17(9-7-15)19-10-18(11-20-22-14-23-24(19)20)25-13-16-4-2-1-3-5-16/h1-11,14H,13H2 WRHATRFGTXCACG-UHFFFAOYSA-N 385713 4-[7-(benzyloxy)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 119 Prolyl hydroxylase EGLN2 Homo sapiens 49.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385713&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540662 404854893 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772223 CC(C)(C)OC(=O)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C18H17N5O2/c1-18(2,3)25-17(24)22-14-8-15(23-16(9-14)20-11-21-23)13-6-4-12(10-19)5-7-13/h4-9,11H,1-3H3,(H,22,24) PKJDSULXJCGSNH-UHFFFAOYSA-N 385714 US10287286, Example 120::tert-butyl N-[5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]carbamate Prolyl hydroxylase EGLN2 Homo sapiens 52.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385714&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540568 404854894 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772224 CC(=O)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C15H11N5O/c1-10(21)19-13-6-14(20-15(7-13)17-9-18-20)12-4-2-11(8-16)3-5-12/h2-7,9H,1H3,(H,19,21) PTTWJWRRPHSFRN-UHFFFAOYSA-N 50239931 CHEMBL4067995::US10287286, Example 142 Prolyl hydroxylase EGLN2 Homo sapiens 8.00 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239931&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 10273543 85714650 CHEMBL4067995 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772225 O=C(Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1)C1CC1 InChI=1S/C17H13N5O/c18-9-11-1-3-12(4-2-11)15-7-14(21-17(23)13-5-6-13)8-16-19-10-20-22(15)16/h1-4,7-8,10,13H,5-6H2,(H,21,23) SMWXNMVLXVAZKH-UHFFFAOYSA-N 385716 N-[5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]cyclopropane- carboxamide::US10287286, Example 122 Prolyl hydroxylase EGLN2 Homo sapiens 70.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385716&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540543 404854896 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772226 O=C(Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1)c1ccccc1 InChI=1S/C20H13N5O/c21-12-14-6-8-15(9-7-14)18-10-17(11-19-22-13-23-25(18)19)24-20(26)16-4-2-1-3-5-16/h1-11,13H,(H,24,26) OXBZAXBNVZSIFP-UHFFFAOYSA-N 385718 N-[5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]benzamide::US10287286, Example 123 Prolyl hydroxylase EGLN2 Homo sapiens 151 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385718&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540733 404854898 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772227 CC(C)(C)OC(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C18H16FN5O2/c1-18(2,3)26-17(25)23-13-7-15(24-16(8-13)21-10-22-24)11-4-5-12(9-20)14(19)6-11/h4-8,10H,1-3H3,(H,23,25) PHEQNCKVSGNNQD-UHFFFAOYSA-N 385719 US10287286, Example 124::tert-butyl N-[5-(4- cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]carbamate Prolyl hydroxylase EGLN2 Homo sapiens 49.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385719&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540552 404854899 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772228 Fc1cc(ccc1C#N)-c1cc(NCC2COC2)cc2ncnn12 InChI=1S/C17H14FN5O/c18-15-3-12(1-2-13(15)6-19)16-4-14(20-7-11-8-24-9-11)5-17-21-10-22-23(16)17/h1-5,10-11,20H,7-9H2 NYUBXXULNBLHOC-UHFFFAOYSA-N 385720 2-fluoro-4-{7- [(oxetan-3- ylmethyl)amino]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 125 Prolyl hydroxylase EGLN2 Homo sapiens 208 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385720&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540431 404854900 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772229 Fc1cc(ccc1C#N)-c1cc(NCCC(F)(F)F)cc2ncnn12 InChI=1S/C16H11F4N5/c17-13-5-10(1-2-11(13)8-21)14-6-12(22-4-3-16(18,19)20)7-15-23-9-24-25(14)15/h1-2,5-7,9,22H,3-4H2 VGCGIXOMVFHOFE-UHFFFAOYSA-N 385721 2-fluoro-4-{7- [(3,3,3- trifluoropropyl)- amino][1,2,4] triazolo- [1,5-a]pyridin-5- yl}benzonitrile::US10287286, Example 126 Prolyl hydroxylase EGLN2 Homo sapiens 53.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385721 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385721&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540564 404854901 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772230 CC1(CNc2cc(-c3ccc(C#N)c(F)c3)n3ncnc3c2)COC1 InChI=1S/C18H16FN5O/c1-18(9-25-10-18)8-21-14-5-16(24-17(6-14)22-11-23-24)12-2-3-13(7-20)15(19)4-12/h2-6,11,21H,8-10H2,1H3 RXMYAFFQPTUGQU-UHFFFAOYSA-N 385722 2-fluoro-4-(7-{[(3- methyloxetan-3- yl)methyl]amino}- [1,2,4]triazolo[1,5- a]pyridin-5- yl)benzonitrile::US10287286, Example 127 Prolyl hydroxylase EGLN2 Homo sapiens 47.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385722&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540288 404854902 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772231 Fc1cc(ccc1C#N)-c1cc(NCC2(COC2)c2ccccc2)cc2ncnn12 InChI=1S/C23H18FN5O/c24-20-8-16(6-7-17(20)11-25)21-9-19(10-22-27-15-28-29(21)22)26-12-23(13-30-14-23)18-4-2-1-3-5-18/h1-10,15,26H,12-14H2 GKXIHGMCEFJTEV-UHFFFAOYSA-N 385723 2-fluoro-4-(7-{[(3- phenyloxetan-3- yl)methyl]amino}- [1,2,4]triazolo[1,5- a]pyridin-5- yl)benzonitrile::US10287286, Example 128 Prolyl hydroxylase EGLN2 Homo sapiens 215 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385723&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540420 404854903 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772232 CN(C)CCOc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C17H16FN5O/c1-22(2)5-6-24-14-8-16(23-17(9-14)20-11-21-23)12-3-4-13(10-19)15(18)7-12/h3-4,7-9,11H,5-6H2,1-2H3 OAPDVQQKPUAJKV-UHFFFAOYSA-N 385724 4-{7-[2- (dimethylamino) ethoxy]- [1,2,4]triazolo[1,5- a]pyridin-5-yl}-2- fluorobenzonitrile::US10287286, Example 129 Prolyl hydroxylase EGLN2 Homo sapiens 299 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385724&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540309 404854904 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772233 Fc1cc(ccc1C#N)-c1cc(OCCN2CCCC2)cc2ncnn12 InChI=1S/C19H18FN5O/c20-17-9-14(3-4-15(17)12-21)18-10-16(11-19-22-13-23-25(18)19)26-8-7-24-5-1-2-6-24/h3-4,9-11,13H,1-2,5-8H2 MOVNZCBLDQVSLD-UHFFFAOYSA-N 385725 2-fluoro-4-{7-[2- (pyrrolidin-1- yl)ethoxy]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 130 Prolyl hydroxylase EGLN2 Homo sapiens 139 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385725&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540447 404854905 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772234 Fc1cc(ccc1C#N)-c1cc(OCC2CCCO2)cc2ncnn12 InChI=1S/C18H15FN4O2/c19-16-6-12(3-4-13(16)9-20)17-7-15(8-18-21-11-22-23(17)18)25-10-14-2-1-5-24-14/h3-4,6-8,11,14H,1-2,5,10H2 HTNBFLTXQKEDBA-UHFFFAOYSA-N 385726 2-fluoro-4-[7- oxolan-2- ylmethoxy)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 131 Prolyl hydroxylase EGLN2 Homo sapiens 168 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385726&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540747 404854906 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772235 Fc1cc(ccc1C#N)-c1cc(OCCN2CCCC2=O)cc2ncnn12 InChI=1S/C19H16FN5O2/c20-16-8-13(3-4-14(16)11-21)17-9-15(10-18-22-12-23-25(17)18)27-7-6-24-5-1-2-19(24)26/h3-4,8-10,12H,1-2,5-7H2 DBZINLQIGIGBGR-UHFFFAOYSA-N 385727 2-fluoro-4-{7-[2- (2-oxopyrrolidin-1- yl)ethoxy]- [1,2,4]triazolo[1,5- a]pyridin-5- yl}benzonitrile::US10287286, Example 132 Prolyl hydroxylase EGLN2 Homo sapiens 480 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385727&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540332 404854907 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772236 Fc1cc(ccc1C#N)-c1cc(OCC2CCOC2)cc2ncnn12 InChI=1S/C18H15FN4O2/c19-16-5-13(1-2-14(16)8-20)17-6-15(7-18-21-11-22-23(17)18)25-10-12-3-4-24-9-12/h1-2,5-7,11-12H,3-4,9-10H2 OVLYPFVIMFTQMP-UHFFFAOYSA-N 385728 2-fluoro-4-[7- oxolan-3- ylmethoxy)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 133 Prolyl hydroxylase EGLN2 Homo sapiens 2300 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385728&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540713 404854908 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772237 Fc1cc(ccc1C#N)-c1cc(cc2ncnn12)N1CCCC1=O InChI=1S/C17H12FN5O/c18-14-6-11(3-4-12(14)9-19)15-7-13(22-5-1-2-17(22)24)8-16-20-10-21-23(15)16/h3-4,6-8,10H,1-2,5H2 KPLCYCWZNQGMKF-UHFFFAOYSA-N 385729 2-fluoro-4-[7-(2- oxopyrrolidin-1-yl)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 134 Prolyl hydroxylase EGLN2 Homo sapiens 229 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385729&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540687 404854909 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772238 Fc1cc(ccc1C#N)-c1cc(cc2ncnn12)N1CCOC1=O InChI=1S/C16H10FN5O2/c17-13-5-10(1-2-11(13)8-18)14-6-12(21-3-4-24-16(21)23)7-15-19-9-20-22(14)15/h1-2,5-7,9H,3-4H2 TVVRDIWPFVHQAM-UHFFFAOYSA-N 385730 2-fluoro-4-[7-(2- oxo-1,3- oxazolidin-3-yl)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 135 Prolyl hydroxylase EGLN2 Homo sapiens 240 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385730&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540599 404854910 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772239 CN(C(C)=O)c1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C16H12FN5O/c1-10(23)21(2)13-6-15(22-16(7-13)19-9-20-22)11-3-4-12(8-18)14(17)5-11/h3-7,9H,1-2H3 QUVNUZBSOYUHEP-UHFFFAOYSA-N 385731 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-N- methylacetamide::US10287286, Example 136 Prolyl hydroxylase EGLN2 Homo sapiens 3223 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385731&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540602 404854911 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772240 Fc1cc(ccc1C#N)-c1cc(cc2ncnn12)N1CCOCC1 InChI=1S/C17H14FN5O/c18-15-7-12(1-2-13(15)10-19)16-8-14(22-3-5-24-6-4-22)9-17-20-11-21-23(16)17/h1-2,7-9,11H,3-6H2 IGSPNUAJOLJAKK-UHFFFAOYSA-N 385732 2-fluoro-4-[7- (morpholin-4-yl)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 137 Prolyl hydroxylase EGLN2 Homo sapiens 145 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385732&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540663 404854912 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772241 COC1CN(C1)c1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C17H14FN5O/c1-24-14-8-22(9-14)13-5-16(23-17(6-13)20-10-21-23)11-2-3-12(7-19)15(18)4-11/h2-6,10,14H,8-9H2,1H3 AMCNEQONGMDYSJ-UHFFFAOYSA-N 385733 2-fluoro-4-[7-(3- methoxyazetidin-1- yl)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 138 Prolyl hydroxylase EGLN2 Homo sapiens 170 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385733&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540545 404854913 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772242 CC(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C15H10FN5O/c1-9(22)20-12-5-14(21-15(6-12)18-8-19-21)10-2-3-11(7-17)13(16)4-10/h2-6,8H,1H3,(H,20,22) NLFAQJSYAZZWCJ-UHFFFAOYSA-N 385734 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]acetamide::US10287286, Example 139 Prolyl hydroxylase EGLN2 Homo sapiens 77.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385734&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540627 404854914 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772243 COC1CN(C1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H15N5O/c1-23-15-9-21(10-15)14-6-16(22-17(7-14)19-11-20-22)13-4-2-12(8-18)3-5-13/h2-7,11,15H,9-10H2,1H3 IDORUDAREBTSMG-UHFFFAOYSA-N 385735 4-[7-(3- methoxyazetidin- 1-yl)- [1,2,4]triazolo[1,5- a]pyridin-5- yl]benzonitrile::US10287286, Example 140 Prolyl hydroxylase EGLN2 Homo sapiens 151 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385735&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540660 404854915 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772244 N#Cc1ccc(cc1)-c1cc(cc2ncnn12)N1CC2(COC2)C1 InChI=1S/C18H15N5O/c19-7-13-1-3-14(4-2-13)16-5-15(6-17-20-12-21-23(16)17)22-8-18(9-22)10-24-11-18/h1-6,12H,8-11H2 MQAXAPLBUHZTNL-UHFFFAOYSA-N 385736 4-(7-{2-oxa-6- azaspiro[3.3] heptan-6-yl}- [1,2,4]triazolo[1,5- a]pyridin-5- yl)benzonitrile::US10287286, Example 141 Prolyl hydroxylase EGLN2 Homo sapiens 115 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385736&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540285 404854916 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772245 CC(=O)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C15H11N5O/c1-10(21)19-13-6-14(20-15(7-13)17-9-18-20)12-4-2-11(8-16)3-5-12/h2-7,9H,1H3,(H,19,21) PTTWJWRRPHSFRN-UHFFFAOYSA-N 50239931 CHEMBL4067995::US10287286, Example 142 Prolyl hydroxylase EGLN2 Homo sapiens 72.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239931&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 10273543 85714650 CHEMBL4067995 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772246 CC(C)(C)OC(=O)N1CCN(CC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C22H24N6O2/c1-22(2,3)30-21(29)27-10-8-26(9-11-27)18-12-19(28-20(13-18)24-15-25-28)17-6-4-16(14-23)5-7-17/h4-7,12-13,15H,8-11H2,1-3H3 DOALMKSXYREJPI-UHFFFAOYSA-N 385739 US10287286, Example 143::tert-butyl 4-[5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]piperazine-1- carboxylate Prolyl hydroxylase EGLN2 Homo sapiens 437 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385739&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540400 404854918 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772247 CC(C)(C)OC(=O)N1CC2(C1)CN(C2)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C23H24N6O2/c1-22(2,3)31-21(30)28-13-23(14-28)11-27(12-23)18-8-19(29-20(9-18)25-15-26-29)17-6-4-16(10-24)5-7-17/h4-9,15H,11-14H2,1-3H3 OPWBRHOZHVRWCU-UHFFFAOYSA-N 385740 US10287286, Example 144::tert-butyl 6-[5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2,6- diazaspiro[3.3] heptane- 2-carboxylate Prolyl hydroxylase EGLN2 Homo sapiens 145 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385740&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540652 404854919 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772248 COC(=O)Nc1cc(-c2ccc(cc2C)C#N)n2ncnc2c1 InChI=1S/C16H13N5O2/c1-10-5-11(8-17)3-4-13(10)14-6-12(20-16(22)23-2)7-15-18-9-19-21(14)15/h3-7,9H,1-2H3,(H,20,22) RTVVXJLOUVJINV-UHFFFAOYSA-N 385741 US10287286, Example 145::methyl N-[5-(4- cyano-2- methylphenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]carbamate Prolyl hydroxylase EGLN2 Homo sapiens 66.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385741&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540710 404854920 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772249 Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C13H8FN5/c14-11-3-8(1-2-9(11)6-15)12-4-10(16)5-13-17-7-18-19(12)13/h1-5,7H,16H2 GWXSXJAQYVBOTK-UHFFFAOYSA-N 385742 US10287286, Example 146 Prolyl hydroxylase EGLN2 Homo sapiens 27.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385742&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540622 404854921 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772250 Fc1ccc2ncnn2c1-c1ccc(cc1)C#N InChI=1S/C13H7FN4/c14-11-5-6-12-16-8-17-18(12)13(11)10-3-1-9(7-15)2-4-10/h1-6,8H JFPRQLNDBOCDKC-UHFFFAOYSA-N 50239887 CHEMBL4089934::US10287286, Example 147 Prolyl hydroxylase EGLN2 Homo sapiens 461 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239887&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448698 85714808 CHEMBL4089934 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772251 Fc1cc(ccc1C#N)-c1cc(NS(=O)(=O)C2CC2)cc2ncnn12 InChI=1S/C16H12FN5O2S/c17-14-5-10(1-2-11(14)8-18)15-6-12(7-16-19-9-20-22(15)16)21-25(23,24)13-3-4-13/h1-2,5-7,9,13,21H,3-4H2 GVFTZNIEVIEAGU-UHFFFAOYSA-N 385745 US10287286, Example 148 Prolyl hydroxylase EGLN2 Homo sapiens 126 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385745&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540734 404854924 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772252 Fc1cc(ccc1C#N)-c1cc(NS(=O)(=O)c2ccccc2)cc2ncnn12 InChI=1S/C19H12FN5O2S/c20-17-8-13(6-7-14(17)11-21)18-9-15(10-19-22-12-23-25(18)19)24-28(26,27)16-4-2-1-3-5-16/h1-10,12,24H ZSIXCCOEHXAWEX-UHFFFAOYSA-N 385746 US10287286, Example 149 Prolyl hydroxylase EGLN2 Homo sapiens 252 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385746&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328390 404854925 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772253 Fc1cc(ccc1C#N)-c1cc(NC(=O)Nc2ccccc2)cc2ncnn12 InChI=1S/C20H13FN6O/c21-17-8-13(6-7-14(17)11-22)18-9-16(10-19-23-12-24-27(18)19)26-20(28)25-15-4-2-1-3-5-15/h1-10,12H,(H2,25,26,28) BHBTZAUVKXSOJJ-UHFFFAOYSA-N 385747 US10287286, Example 150 Prolyl hydroxylase EGLN2 Homo sapiens 12.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385747&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540282 404854926 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772254 COCCC(=O)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H15N5O2/c1-24-7-6-17(23)21-14-8-15(22-16(9-14)19-11-20-22)13-4-2-12(10-18)3-5-13/h2-5,8-9,11H,6-7H2,1H3,(H,21,23) DUNVYKROXZDEGT-UHFFFAOYSA-N 385748 N-[5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-3- methoxy- propanamide::US10287286, Example 151 Prolyl hydroxylase EGLN2 Homo sapiens 47.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385748&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540289 404854927 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772255 O=C(Cc1ccccc1)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C21H15N5O/c22-13-16-6-8-17(9-7-16)19-11-18(12-20-23-14-24-26(19)20)25-21(27)10-15-4-2-1-3-5-15/h1-9,11-12,14H,10H2,(H,25,27) JRHAOBSKRZJMBX-UHFFFAOYSA-N 385749 N-[5-(4- cyanophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2- phenylacetamide::US10287286, Example 152 Prolyl hydroxylase EGLN2 Homo sapiens 42.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385749&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540586 404854928 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772256 FC(F)(F)CC(=O)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C16H10F3N5O/c17-16(18,19)7-15(25)23-12-5-13(24-14(6-12)21-9-22-24)11-3-1-10(8-20)2-4-11/h1-6,9H,7H2,(H,23,25) KYQFUMHAYKPVQG-UHFFFAOYSA-N 385750 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]- 3,3,3- trifluoro- propanamide::US10287286, Example 153 Prolyl hydroxylase EGLN2 Homo sapiens 28.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385750&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134334917 404854929 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772257 COCC(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C16H12FN5O2/c1-24-8-16(23)21-12-5-14(22-15(6-12)19-9-20-22)10-2-3-11(7-18)13(17)4-10/h2-6,9H,8H2,1H3,(H,21,23) OHOWYXITQIKSMS-UHFFFAOYSA-N 385751 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2- methoxyacetamide::US10287286, Example 154 Prolyl hydroxylase EGLN2 Homo sapiens 490 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385751&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540723 404854930 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772258 Fc1cc(ccc1C#N)-c1cc(NC(=O)C2CCC2)cc2ncnn12 InChI=1S/C18H14FN5O/c19-15-6-12(4-5-13(15)9-20)16-7-14(8-17-21-10-22-24(16)17)23-18(25)11-2-1-3-11/h4-8,10-11H,1-3H2,(H,23,25) KNWCVKCQYXQFAS-UHFFFAOYSA-N 385752 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl] cyclobutane- carboxamide::US10287286, Example 155 Prolyl hydroxylase EGLN2 Homo sapiens 130 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385752&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540695 404854931 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772259 Fc1cc(ccc1C#N)-c1cc(NC(=O)CC2CCOCC2)cc2ncnn12 InChI=1S/C20H18FN5O2/c21-17-8-14(1-2-15(17)11-22)18-9-16(10-19-23-12-24-26(18)19)25-20(27)7-13-3-5-28-6-4-13/h1-2,8-10,12-13H,3-7H2,(H,25,27) AGMBCMBVTBGQHK-UHFFFAOYSA-N 385753 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2- (oxan-4-yl)acetamide::US10287286, Example 156 Prolyl hydroxylase EGLN2 Homo sapiens 129 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385753&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540579 404854932 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772260 CC1CC1C(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C18H14FN5O/c1-10-4-14(10)18(25)23-13-6-16(24-17(7-13)21-9-22-24)11-2-3-12(8-20)15(19)5-11/h2-3,5-7,9-10,14H,4H2,1H3,(H,23,25) VVARASXIQIPEOX-UHFFFAOYSA-N 385754 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2- methyl- cyclopropane- 1-carboxamide::US10287286, Example 157 Prolyl hydroxylase EGLN2 Homo sapiens 57.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385754&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540609 404854933 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772261 Fc1cc(ccc1C#N)-c1cc(NC(=O)CN2CCCCC2)cc2ncnn12 InChI=1S/C20H19FN6O/c21-17-8-14(4-5-15(17)11-22)18-9-16(10-19-23-13-24-27(18)19)25-20(28)12-26-6-2-1-3-7-26/h4-5,8-10,13H,1-3,6-7,12H2,(H,25,28) GXHZGUGQNLOZMX-UHFFFAOYSA-N 385755 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2- (piperidin-1- yl)acetamide::US10287286, Example 158 Prolyl hydroxylase EGLN2 Homo sapiens 91.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385755&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540696 404854934 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772262 Fc1cc(ccc1C#N)-c1cc(NC(=O)[C@@H]2CCCO2)cc2ncnn12 InChI=1S/C18H14FN5O2/c19-14-6-11(3-4-12(14)9-20)15-7-13(8-17-21-10-22-24(15)17)23-18(25)16-2-1-5-26-16/h3-4,6-8,10,16H,1-2,5H2,(H,23,25)/t16-/m0/s1 OUUKGGARMJMPSU-INIZCTEOSA-N 385756 (2S)-N-[5-(4-cyano- 3-fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]oxolane-2- carboxamide::US10287286, Example 159::US10287286, Example 160 Prolyl hydroxylase EGLN2 Homo sapiens 147 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385756&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540764 404854935 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772263 Fc1cc(ccc1C#N)-c1cc(NC(=O)[C@@H]2CCCO2)cc2ncnn12 InChI=1S/C18H14FN5O2/c19-14-6-11(3-4-12(14)9-20)15-7-13(8-17-21-10-22-24(15)17)23-18(25)16-2-1-5-26-16/h3-4,6-8,10,16H,1-2,5H2,(H,23,25)/t16-/m0/s1 OUUKGGARMJMPSU-INIZCTEOSA-N 385756 (2S)-N-[5-(4-cyano- 3-fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]oxolane-2- carboxamide::US10287286, Example 159::US10287286, Example 160 Prolyl hydroxylase EGLN2 Homo sapiens 248 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385756&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540764 404854935 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772264 CN(C)CC(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C17H15FN6O/c1-23(2)9-17(25)22-13-6-15(24-16(7-13)20-10-21-24)11-3-4-12(8-19)14(18)5-11/h3-7,10H,9H2,1-2H3,(H,22,25) PCJZGCNAUIEGIR-UHFFFAOYSA-N 385758 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2- (dimethylamino) acetamide::US10287286, Example 161 Prolyl hydroxylase EGLN2 Homo sapiens 123 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385758&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540403 404854936 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772265 Fc1cc(ccc1C#N)-c1cc(NC(=O)C2CCOC2)cc2ncnn12 InChI=1S/C18H14FN5O2/c19-15-5-11(1-2-12(15)8-20)16-6-14(7-17-21-10-22-24(16)17)23-18(25)13-3-4-26-9-13/h1-2,5-7,10,13H,3-4,9H2,(H,23,25) HKQJTNMAMVRCEK-UHFFFAOYSA-N 385759 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]oxolane-3- carboxamide::US10287286, Example 162 Prolyl hydroxylase EGLN2 Homo sapiens 117 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385759&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540672 404854937 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772266 CC1(CC1)C(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C18H14FN5O/c1-18(4-5-18)17(25)23-13-7-15(24-16(8-13)21-10-22-24)11-2-3-12(9-20)14(19)6-11/h2-3,6-8,10H,4-5H2,1H3,(H,23,25) CUYXRLSXQHIJGQ-UHFFFAOYSA-N 385760 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-1- methyl- cyclopropane- 1-carboxamide::US10287286, Example 163 Prolyl hydroxylase EGLN2 Homo sapiens 88.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385760&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540578 404854938 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772267 Fc1cc(ccc1C#N)-c1cc(NC(=O)C2CCCOC2)cc2ncnn12 InChI=1S/C19H16FN5O2/c20-16-6-12(3-4-13(16)9-21)17-7-15(8-18-22-11-23-25(17)18)24-19(26)14-2-1-5-27-10-14/h3-4,6-8,11,14H,1-2,5,10H2,(H,24,26) KHFHDZBRLLQNHL-UHFFFAOYSA-N 385761 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]oxane-3- carboxamide::US10287286, Example 164 Prolyl hydroxylase EGLN2 Homo sapiens 131 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385761&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540762 404854939 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772268 CC1(CCOCC1)C(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C20H18FN5O2/c1-20(4-6-28-7-5-20)19(27)25-15-9-17(26-18(10-15)23-12-24-26)13-2-3-14(11-22)16(21)8-13/h2-3,8-10,12H,4-7H2,1H3,(H,25,27) VZGYESHGCNJQID-UHFFFAOYSA-N 385762 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-4- methyloxane-4- carboxamide::US10287286, Example 165 Prolyl hydroxylase EGLN2 Homo sapiens 650 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385762&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540735 404854940 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772269 CC1(COC1)C(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C18H14FN5O2/c1-18(8-26-9-18)17(25)23-13-5-15(24-16(6-13)21-10-22-24)11-2-3-12(7-20)14(19)4-11/h2-6,10H,8-9H2,1H3,(H,23,25) FSIXIAPEJFNDOD-UHFFFAOYSA-N 385763 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-3- methyloxetane-3- carboxamide::US10287286, Example 166 Prolyl hydroxylase EGLN2 Homo sapiens 630 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385763&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540738 404854941 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772270 Fc1cc(ccc1C#N)-c1cc(NC(=O)C2COC2)cc2ncnn12 InChI=1S/C17H12FN5O2/c18-14-3-10(1-2-11(14)6-19)15-4-13(5-16-20-9-21-23(15)16)22-17(24)12-7-25-8-12/h1-5,9,12H,7-8H2,(H,22,24) PNFRXPLISINJNC-UHFFFAOYSA-N 385764 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]oxetane-3- carboxamide::US10287286, Example 167 Prolyl hydroxylase EGLN2 Homo sapiens 225 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385764&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540326 404854942 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772271 Fc1cc(ccc1C#N)-c1cc(NC(=O)C2CC2(F)F)cc2ncnn12 InChI=1S/C17H10F3N5O/c18-13-3-9(1-2-10(13)7-21)14-4-11(5-15-22-8-23-25(14)15)24-16(26)12-6-17(12,19)20/h1-5,8,12H,6H2,(H,24,26) WIOXTBUBGWILPP-UHFFFAOYSA-N 385765 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2,2- difluoro- cyclopropane- 1-carboxamide::US10287286, Example 168 Prolyl hydroxylase EGLN2 Homo sapiens 218 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385765&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540731 404854943 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772272 Fc1cc(ccc1C#N)-c1cc(NC(=O)CC2CC2)cc2ncnn12 InChI=1S/C18H14FN5O/c19-15-6-12(3-4-13(15)9-20)16-7-14(8-17-21-10-22-24(16)17)23-18(25)5-11-1-2-11/h3-4,6-8,10-11H,1-2,5H2,(H,23,25) UHZBVANUVKROCY-UHFFFAOYSA-N 385766 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-5-yl]-2- cyclopropyl- acetamide::US10287286, Example 169 Prolyl hydroxylase EGLN2 Homo sapiens 49.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385766&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540618 404854944 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772273 COC(C)(C)C(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C18H16FN5O2/c1-18(2,26-3)17(25)23-13-7-15(24-16(8-13)21-10-22-24)11-4-5-12(9-20)14(19)6-11/h4-8,10H,1-3H3,(H,23,25) KIGRYOILNDDRNN-UHFFFAOYSA-N 385767 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl)-2- methoxy-2- methyl- propanamide::US10287286, Example 170 Prolyl hydroxylase EGLN2 Homo sapiens 3017 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385767&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540732 404854945 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772274 Fc1cc(ccc1C#N)-c1cc(NC(=O)C2(CC2)C#N)cc2ncnn12 InChI=1S/C18H11FN6O/c19-14-5-11(1-2-12(14)8-20)15-6-13(7-16-22-10-23-25(15)16)24-17(26)18(9-21)3-4-18/h1-2,5-7,10H,3-4H2,(H,24,26) QMZYXVFPQKWUCP-UHFFFAOYSA-N 385768 1-cyano-N-[5-(4- cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7- yl]cyclopropane-1- carboxamide::US10287286, Example 171 Prolyl hydroxylase EGLN2 Homo sapiens 58.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385768&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540615 404854946 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772275 FC1CC(C1)C(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C18H13F2N5O/c19-13-3-12(4-13)18(26)24-14-6-16(25-17(7-14)22-9-23-25)10-1-2-11(8-21)15(20)5-10/h1-2,5-7,9,12-13H,3-4H2,(H,24,26) RBCCWUJRBHHFSC-UHFFFAOYSA-N 385769 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-3- fluorocyclobutane- 1-carboxamide::US10287286, Example 172 Prolyl hydroxylase EGLN2 Homo sapiens 220 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385769&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540348 404854947 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772276 Fc1cc(ccc1C#N)-c1cc(NC(=O)CC2COC2)cc2ncnn12 InChI=1S/C18H14FN5O2/c19-15-4-12(1-2-13(15)7-20)16-5-14(6-17-21-10-22-24(16)17)23-18(25)3-11-8-26-9-11/h1-2,4-6,10-11H,3,8-9H2,(H,23,25) OFQIHMZPWBHZJH-UHFFFAOYSA-N 385770 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]-2- (oxetan-3- yl)acetamide::US10287286, Example 173 Prolyl hydroxylase EGLN2 Homo sapiens 63.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385770&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540741 404854948 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772277 Fc1cc(ccc1C#N)-c1cc(NC(=O)C2CC2)cc2ncnn12 InChI=1S/C17H12FN5O/c18-14-5-11(3-4-12(14)8-19)15-6-13(22-17(24)10-1-2-10)7-16-20-9-21-23(15)16/h3-7,9-10H,1-2H2,(H,22,24) KIDNTTIYEICQIJ-UHFFFAOYSA-N 385771 N-[5-(4-cyano-3- fluorophenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl] cyclopropane- carboxamide::US10287286, Example 174 Prolyl hydroxylase EGLN2 Homo sapiens 34.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385771&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540620 404854949 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772278 Cc1cc(ccc1-c1cc(NC(=O)CC(F)(F)F)cc2ncnn12)C#N InChI=1S/C17H12F3N5O/c1-10-4-11(8-21)2-3-13(10)14-5-12(6-15-22-9-23-25(14)15)24-16(26)7-17(18,19)20/h2-6,9H,7H2,1H3,(H,24,26) JDQJVFORFISJLJ-UHFFFAOYSA-N 385772 N-[5-(4-cyano-2- methylphenyl)- [1,2,4]triazolo[1,5- a]pyridin-7-yl]- 3,3,3- trifluoro- propanamide::US10287286, Example 175 Prolyl hydroxylase EGLN2 Homo sapiens 143 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385772&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540669 404854950 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772279 N#Cc1ccc(cc1)-c1cc(SCc2ccccc2)cc2ncnn12 InChI=1S/C20H14N4S/c21-12-15-6-8-17(9-7-15)19-10-18(11-20-22-14-23-24(19)20)25-13-16-4-2-1-3-5-16/h1-11,14H,13H2 HNUCQKUWOZDYFO-UHFFFAOYSA-N 385773 US10287286, Example 176 Prolyl hydroxylase EGLN2 Homo sapiens 40.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385773&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540631 404854951 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772280 O=S(=O)(NCC1CC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H15N5O2S/c18-9-12-3-5-14(6-4-12)16-7-15(8-17-19-11-20-22(16)17)25(23,24)21-10-13-1-2-13/h3-8,11,13,21H,1-2,10H2 FKAGHRYUKLRFOX-UHFFFAOYSA-N 385774 US10287286, Example 177 Prolyl hydroxylase EGLN2 Homo sapiens 6900 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385774&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540291 404854952 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772281 CN(C)CCNS(=O)(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H18N6O2S/c1-22(2)8-7-21-26(24,25)15-9-16(23-17(10-15)19-12-20-23)14-5-3-13(11-18)4-6-14/h3-6,9-10,12,21H,7-8H2,1-2H3 BPNLOIPAXMBVJV-UHFFFAOYSA-N 385775 US10287286, Example 178 Prolyl hydroxylase EGLN2 Homo sapiens 4000 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385775&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540598 404854953 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772282 FC(F)CNS(=O)(=O)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C15H11F2N5O2S/c16-14(17)8-21-25(23,24)12-5-13(22-15(6-12)19-9-20-22)11-3-1-10(7-18)2-4-11/h1-6,9,14,21H,8H2 SWAAPJNSIYUHJW-UHFFFAOYSA-N 385776 US10287286, Example 179 Prolyl hydroxylase EGLN2 Homo sapiens 3300 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385776&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122550603 404854954 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772283 O=C(CN1CCC1)Nc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C18H16N6O/c19-10-13-2-4-14(5-3-13)16-8-15(9-17-20-12-21-24(16)17)22-18(25)11-23-6-1-7-23/h2-5,8-9,12H,1,6-7,11H2,(H,22,25) SANJZTJYISVNMU-UHFFFAOYSA-N 385777 US10287286, Example 180 Prolyl hydroxylase EGLN2 Homo sapiens 79.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385777&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540536 404854955 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772284 Nc1cc2ncnn2c(c1F)-c1ccc(cc1)C#N InChI=1S/C13H8FN5/c14-12-10(16)5-11-17-7-18-19(11)13(12)9-3-1-8(6-15)2-4-9/h1-5,7H,16H2 QMHVUOAGWLRDPP-UHFFFAOYSA-N 385778 US10287286, Example 181 Prolyl hydroxylase EGLN2 Homo sapiens 325 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385778&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540310 404854956 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772285 C#Cc1ccc(cc1)-c1cccc2ncnn12 InChI=1S/C14H9N3/c1-2-11-6-8-12(9-7-11)13-4-3-5-14-15-10-16-17(13)14/h1,3-10H SZXOXIUXMHQIGQ-UHFFFAOYSA-N 385779 US10287286, Example 182 Prolyl hydroxylase EGLN2 Homo sapiens 5400 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385779&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540753 404854957 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772286 CC(C)NCc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C17H17N5/c1-12(2)19-10-14-7-16(22-17(8-14)20-11-21-22)15-5-3-13(9-18)4-6-15/h3-8,11-12,19H,10H2,1-2H3 QBFUVYJSQOPYSY-UHFFFAOYSA-N 385780 4-(7-{[(propan-2-yl)amino]methyl}- [1,2,4]triazolo[1,5-a]pyridin-5- yl)benzonitrile::US10287286, Example 183 Prolyl hydroxylase EGLN2 Homo sapiens 1500 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385780&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540311 404854958 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772287 FC(F)(F)CNCc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C16H12F3N5/c17-16(18,19)9-21-8-12-5-14(24-15(6-12)22-10-23-24)13-3-1-11(7-20)2-4-13/h1-6,10,21H,8-9H2 KHGDXQZJKLJOIK-UHFFFAOYSA-N 385781 4-(7-{[(2,2,2- trifluoroethyl)amino]methyl}- [1,2,4]triazolo[1,5-a]pyridin-5- yl)benzonitrile::US10287286, Example 184 Prolyl hydroxylase EGLN2 Homo sapiens 870 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385781&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540727 404854959 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772288 N#Cc1ccc(cc1)-c1cc(CNC2COC2)cc2ncnn12 InChI=1S/C17H15N5O/c18-7-12-1-3-14(4-2-12)16-5-13(8-19-15-9-23-10-15)6-17-20-11-21-22(16)17/h1-6,11,15,19H,8-10H2 RPHRBKTVHVYIHZ-UHFFFAOYSA-N 385782 4-(7-{[(oxetan-3-yl)amino]methyl}- [1,2,4]triazolo[1,5-a]pyridin-5- yl)benzonitrile::US10287286, Example 185 Prolyl hydroxylase EGLN2 Homo sapiens 3794 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385782&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540611 404854960 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772289 N#Cc1ccc(cc1)-c1cc(CNCC2COC2)cc2ncnn12 InChI=1S/C18H17N5O/c19-7-13-1-3-16(4-2-13)17-5-14(6-18-21-12-22-23(17)18)8-20-9-15-10-24-11-15/h1-6,12,15,20H,8-11H2 MRVPHJBVQHRMMO-UHFFFAOYSA-N 385783 4-(7-{[(oxetan-3- ylmethyl)amino]methyl}- [1,2,4]triazolo[1,5-a]pyridin-5- yl)benzonitrile::US10287286, Example 186 Prolyl hydroxylase EGLN2 Homo sapiens 1400 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385783&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540342 404854961 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772290 FC(F)CNCc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C16H13F2N5/c17-15(18)9-20-8-12-5-14(23-16(6-12)21-10-22-23)13-3-1-11(7-19)2-4-13/h1-6,10,15,20H,8-9H2 LXMQJJCMQAWJPY-UHFFFAOYSA-N 385784 4-(7-{[(2,2- difluoroethyl)amino]methyl}- [1,2,4]triazolo[1,5-a]pyridin-5- yl)benzonitrile::US10287286, Example 187 Prolyl hydroxylase EGLN2 Homo sapiens 1400 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385784&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540748 404854962 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772291 Clc1cccc(CNCc2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C21H16ClN5/c22-19-3-1-2-16(8-19)12-24-13-17-9-20(27-21(10-17)25-14-26-27)18-6-4-15(11-23)5-7-18/h1-10,14,24H,12-13H2 NFTGYPZWMRZEGY-UHFFFAOYSA-N 385785 4-[7-({[(3-chlorophenyl) methyl]amino}methyl)- [1,2,4]triazolo[1,5-c]pyridin-5- yl]benzonitrile::US10287286, Example 188 Prolyl hydroxylase EGLN2 Homo sapiens 800 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385785&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540565 404854963 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772292 N#Cc1ccc(cc1)-c1cc(CNCC2CC2)cc2ncnn12 InChI=1S/C18H17N5/c19-9-13-3-5-16(6-4-13)17-7-15(11-20-10-14-1-2-14)8-18-21-12-22-23(17)18/h3-8,12,14,20H,1-2,10-11H2 LHSJZUZENFRTQN-UHFFFAOYSA-N 385786 4-(7-{[(cyclopropylmethyl) amino]methyl}- [1,2,4]triazolo[1,5-a]pyridin-5- yl)benzonitrile::US10287286, Example 189 Prolyl hydroxylase EGLN2 Homo sapiens 1300 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385786&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540406 404854964 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772293 COc1cccc(CNCc2cc(-c3ccc(cc3)C#N)n3ncnc3c2)c1 InChI=1S/C22H19N5O/c1-28-20-4-2-3-17(9-20)13-24-14-18-10-21(27-22(11-18)25-15-26-27)19-7-5-16(12-23)6-8-19/h2-11,15,24H,13-14H2,1H3 JBBRAMDPDPDLRH-UHFFFAOYSA-N 385787 4-[7-({[(3-methoxyphenyl) methyl]amino}methyl)- [1,2,4]triazolo[1,5-a]pyridin-5- yl]benzonitrile::US10287286, Example 190 Prolyl hydroxylase EGLN2 Homo sapiens 1700 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385787&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540700 404854965 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772294 COC1CN(Cc2cc(-c3ccc(cc3)C#N)n3ncnc3c2)C1 InChI=1S/C18H17N5O/c1-24-16-10-22(11-16)9-14-6-17(23-18(7-14)20-12-21-23)15-4-2-13(8-19)3-5-15/h2-7,12,16H,9-11H2,1H3 MDKKZNUUJXLVNX-UHFFFAOYSA-N 385788 4-{7-[(3-methoxyazetidin-1- yl)methyl]-[1,2,4]triazolo[1,5- a]pyridin-5-yl}benzonitrile::US10287286, Example 191 Prolyl hydroxylase EGLN2 Homo sapiens 2900 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385788&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540319 404854966 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772295 N#Cc1ccc(cc1)-c1cc(CNC2CCOC2)cc2ncnn12 InChI=1S/C18H17N5O/c19-9-13-1-3-15(4-2-13)17-7-14(8-18-21-12-22-23(17)18)10-20-16-5-6-24-11-16/h1-4,7-8,12,16,20H,5-6,10-11H2 ULZXKIMTJAMTGW-UHFFFAOYSA-N 385789 4-(7-{[(oxolan-3-yl)amino]methyl}- [1,2,4]triazolo[1,5-a]pyridin-5- yl)benzonitrile::US10287286, Example 192 Prolyl hydroxylase EGLN2 Homo sapiens 1300 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385789&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540466 404854967 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772296 N#Cc1ccc(cc1)-c1cc(CNCC2CCOC2)cc2ncnn12 InChI=1S/C19H19N5O/c20-9-14-1-3-17(4-2-14)18-7-16(8-19-22-13-23-24(18)19)11-21-10-15-5-6-25-12-15/h1-4,7-8,13,15,21H,5-6,10-12H2 YCTGJNCLJUMGQS-UHFFFAOYSA-N 385790 4-(7-{[(oxolan-3- ylmethyl)amino]methyl}- [1,2,4]triazolo[1,5-a]pyridin-5- yl)benzonitrile::US10287286, Example 193 Prolyl hydroxylase EGLN2 Homo sapiens 4800 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385790&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540729 404854968 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772297 N#Cc1ccc(cc1)-c1cc(CNC2CC2)cc2ncnn12 InChI=1S/C17H15N5/c18-9-12-1-3-14(4-2-12)16-7-13(10-19-15-5-6-15)8-17-20-11-21-22(16)17/h1-4,7-8,11,15,19H,5-6,10H2 VXNXXGHJCBFMJK-UHFFFAOYSA-N 385791 4-{7-[(cyclopropylamino)methyl]- [1,2,4]triazolo[1,5-a]pyridin-5- yl}benzonitrile::US10287286, Example 194 Prolyl hydroxylase EGLN2 Homo sapiens 2300 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385791&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540286 404854969 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772298 Fc1cc(ccc1C#N)-c1cc(NC(=O)OCC2CC2)cc2ncnn12 InChI=1S/C18H14FN5O2/c19-15-5-12(3-4-13(15)8-20)16-6-14(7-17-21-10-22-24(16)17)23-18(25)26-9-11-1-2-11/h3-7,10-11H,1-2,9H2,(H,23,25) HALMVMOOYFNWCX-UHFFFAOYSA-N 385792 US10287286, Example 195::cyclopropylmethyl N-[5-(4- cyano-3-fluorophenyl)- [1,2,4]triazolo[1,5-a]pyridin- 7-yl]carbamate Prolyl hydroxylase EGLN2 Homo sapiens 14.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385792&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540680 404854970 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772299 COCCOC(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C17H14FN5O3/c1-25-4-5-26-17(24)22-13-7-15(23-16(8-13)20-10-21-23)11-2-3-12(9-19)14(18)6-11/h2-3,6-8,10H,4-5H2,1H3,(H,22,24) FEOUNFBJVTUVKJ-UHFFFAOYSA-N 385793 2-methoxyethyl N-[5-(4- cyano-3-fluorophenyl)- [1,2,4]triazolo[1,5-a]pyridin- 7-yl]carbamate::US10287286, Example 196 Prolyl hydroxylase EGLN2 Homo sapiens 190 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385793&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540624 404854971 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772300 C[Na]1CCC(CC1)OC(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C19H16FN5O2.CH3.Na/c1-3-15(4-2)27-19(26)24-14-8-17(25-18(9-14)22-11-23-25)12-5-6-13(10-21)16(20)7-12;;/h5-9,11,15H,1-4H2,(H,24,26);1H3; UENRDGVAAFJUSV-UHFFFAOYSA-N 385794 1-methylpiperidin-4-yl N-[5- (4-cyano-3 -fluorophenyl)- [1,2,4]triazolo[1,5-a]pyridin- 7-yl]carbamate::US10287286, Example 197 Prolyl hydroxylase EGLN2 Homo sapiens 53.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385794&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 140850307 404854972 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772301 CN(C)CCCOC(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C19H19FN6O2/c1-25(2)6-3-7-28-19(27)24-15-9-17(26-18(10-15)22-12-23-26)13-4-5-14(11-21)16(20)8-13/h4-5,8-10,12H,3,6-7H2,1-2H3,(H,24,27) GDKTZFXYPXBDTL-UHFFFAOYSA-N 385795 3-(dimethylamino)propyl N- [5-(4-cyano-3-fluorophenyl)- [1,2,4]triazolo[1,5-a]pyridin- 7-yl]carbamate::US10287286, Example 198 Prolyl hydroxylase EGLN2 Homo sapiens 109 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385795&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540569 404854973 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772302 CN(C)CCOC(=O)Nc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C18H17FN6O2/c1-24(2)5-6-27-18(26)23-14-8-16(25-17(9-14)21-11-22-25)12-3-4-13(10-20)15(19)7-12/h3-4,7-9,11H,5-6H2,1-2H3,(H,23,26) VYXDUACUDNVIPB-UHFFFAOYSA-N 385796 2-(dimethylamino)ethyl N-[5- (4-cyano-3-fluorophenyl)- [1,2,4]triazolo[1,5-a]pyridin- 7-yl]carbamate::US10287286, Example 199 Prolyl hydroxylase EGLN2 Homo sapiens 111 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385796&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540635 404854974 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772303 Fc1cc(ccc1C#N)-c1cc(NC(=O)OC2CCOC2)cc2ncnn12 InChI=1S/C18H14FN5O3/c19-15-5-11(1-2-12(15)8-20)16-6-13(7-17-21-10-22-24(16)17)23-18(25)27-14-3-4-26-9-14/h1-2,5-7,10,14H,3-4,9H2,(H,23,25) UXBPOYIPTITXBH-UHFFFAOYSA-N 385797 US10287286, Example 200::oxolan-3-yl N-[5-(4-cyano-3- fluorophenyl)-[1,2,4]triazolo [1,5-a]pyridin-7-yl]carbamate Prolyl hydroxylase EGLN2 Homo sapiens 79.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385797&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540679 404854975 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772304 Fc1cc(ccc1C#N)-c1ccnc2ncnn12 InChI=1S/C12H6FN5/c13-10-5-8(1-2-9(10)6-14)11-3-4-15-12-16-7-17-18(11)12/h1-5,7H DMHSDHOAZBKLGI-UHFFFAOYSA-N 385798 2-fluoro-4-{[1,2,4]triazolo[1,5- a]pyrimidin-7-yl}benzonitrile::US10287286, Example 201 Prolyl hydroxylase EGLN2 Homo sapiens 1125 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385798&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328457 404854976 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772305 Fc1cc(cc(F)c1C#N)-c1ccnc2ncnn12 InChI=1S/C12H5F2N5/c13-9-3-7(4-10(14)8(9)5-15)11-1-2-16-12-17-6-18-19(11)12/h1-4,6H QLEDNZYYWMZGFZ-UHFFFAOYSA-N 385799 2,6-difluoro-4-{[1,2,4]triazolo[1,5- a]pyrimidin-7-yl}benzonitrile::US10287286, Example 202 Prolyl hydroxylase EGLN2 Homo sapiens 4475 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385799&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328560 404854977 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772306 Fc1cc(ccc1-c1ccnc2ncnn12)C#N InChI=1S/C12H6FN5/c13-10-5-8(6-14)1-2-9(10)11-3-4-15-12-16-7-17-18(11)12/h1-5,7H LTFLXHVZMSFICM-UHFFFAOYSA-N 385800 3-fluoro-4-{[1,2,4]triazolo[1,5- a]pyrimidin-7-yl}benzonitrile::US10287286, Example 203 Prolyl hydroxylase EGLN2 Homo sapiens 1109 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385800&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540763 404854978 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772307 Cc1cc(ccc1-c1ccnc2ncnn12)C#N InChI=1S/C13H9N5/c1-9-6-10(7-14)2-3-11(9)12-4-5-15-13-16-8-17-18(12)13/h2-6,8H,1H3 BWUIPIKBBAYWSX-UHFFFAOYSA-N 385801 3-methyl-4-{[1,2,4]triazolo[1,5- a]pyrimidin-7-yl}benzonitrile::US10287286, Example 204 Prolyl hydroxylase EGLN2 Homo sapiens 468 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385801&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540645 404854979 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772308 Clc1cc(ccc1-c1ccnc2ncnn12)C#N InChI=1S/C12H6ClN5/c13-10-5-8(6-14)1-2-9(10)11-3-4-15-12-16-7-17-18(11)12/h1-5,7H IYCGADQTWTWFTD-UHFFFAOYSA-N 385802 3-chloro-4-{[1,2,4]triazolo[1,5- a]pyrimidin-7-yl}benzonitrile::US10287286, Example 205 Prolyl hydroxylase EGLN2 Homo sapiens 970 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385802&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 134328559 404854980 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772309 Fc1cc(cnc1C#N)-c1ccnc2ncnn12 InChI=1S/C11H5FN6/c12-8-3-7(5-15-9(8)4-13)10-1-2-14-11-16-6-17-18(10)11/h1-3,5-6H AOLFAECNRPNKEH-UHFFFAOYSA-N 385803 3-fluoro-5-{[1,2,4]triazolo[1,5- a]pyrimidin-7-yl}pyridine-2- carbonitrile::US10287286, Example 206 Prolyl hydroxylase EGLN2 Homo sapiens 3623 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385803&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540677 404854981 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772310 Fc1c(F)c(ccc1C#N)-c1ccnc2ncnn12 InChI=1S/C12H5F2N5/c13-10-7(5-15)1-2-8(11(10)14)9-3-4-16-12-17-6-18-19(9)12/h1-4,6H XHLZJRGYSHWXNT-UHFFFAOYSA-N 385804 2,3-difluoro-4-{[1,2,4]triazolo[1,5- a]pyrimidin-7-yl}benzonitrile::US10287286, Example 207 Prolyl hydroxylase EGLN2 Homo sapiens 2663 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385804&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540576 404854982 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772311 Cc1cc(C#N)c(F)cc1-c1ccnc2ncnn12 InChI=1S/C13H8FN5/c1-8-4-9(6-15)11(14)5-10(8)12-2-3-16-13-17-7-18-19(12)13/h2-5,7H,1H3 ZBBYJIQMEDTWRK-UHFFFAOYSA-N 385806 2-fluoro-5-methyl-4- {[1,2,4]triazolo[1,5-a]pyrimidin-7- yl}benzonitrile::US10287286, Example 208 Prolyl hydroxylase EGLN2 Homo sapiens 2531 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385806&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540659 404854984 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772312 Cc1cc(ccc1-c1cc(N)cc2ncnn12)C#N InChI=1S/C14H11N5/c1-9-4-10(7-15)2-3-12(9)13-5-11(16)6-14-17-8-18-19(13)14/h2-6,8H,16H2,1H3 DAEJAOGCSBFGTO-UHFFFAOYSA-N 50239910 CHEMBL4073446::US10287286, Example 209 Prolyl hydroxylase EGLN2 Homo sapiens 88.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239910&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448989 85715292 CHEMBL4073446 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772313 Nc1cc(-c2ccc(cc2F)C#N)n2ncnc2c1 InChI=1S/C13H8FN5/c14-11-3-8(6-15)1-2-10(11)12-4-9(16)5-13-17-7-18-19(12)13/h1-5,7H,16H2 VNYPOTBWRCUJAW-UHFFFAOYSA-N 385808 US10287286, Example 210 Prolyl hydroxylase EGLN2 Homo sapiens 36.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385808&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540283 404854986 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772314 Cc1nc(nc(C)c1-c1cccc2ncnn12)C#N InChI=1S/C13H10N6/c1-8-13(9(2)18-11(6-14)17-8)10-4-3-5-12-15-7-16-19(10)12/h3-5,7H,1-2H3 BOCBZMIXGXBPRK-UHFFFAOYSA-N 385809 US10287286, Example 211 Prolyl hydroxylase EGLN2 Homo sapiens 25.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385809&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540681 404854987 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772315 Cc1nc(ccc1-c1cc(N)cc2ncnn12)C#N InChI=1S/C13H10N6/c1-8-11(3-2-10(6-14)18-8)12-4-9(15)5-13-16-7-17-19(12)13/h2-5,7H,15H2,1H3 JAXSSSXHKOWZPV-UHFFFAOYSA-N 385810 US10287286, Example 212 Prolyl hydroxylase EGLN2 Homo sapiens 79.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385810&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540547 404854988 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772316 COc1cc(ccc1Cl)-c1cccc2ncnn12 InChI=1S/C13H10ClN3O/c1-18-12-7-9(5-6-10(12)14)11-3-2-4-13-15-8-16-17(11)13/h2-8H,1H3 QNDWEZDBQKXRCL-UHFFFAOYSA-N 385811 US10287286, Example 213 Prolyl hydroxylase EGLN2 Homo sapiens 7142 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385811&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540665 404854989 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772317 Fc1ccc2ncnn2c1-c1ccc(C#N)c(F)c1 InChI=1S/C13H6F2N4/c14-10-3-4-12-17-7-18-19(12)13(10)8-1-2-9(6-16)11(15)5-8/h1-5,7H OGXGCIBHOYGYDL-UHFFFAOYSA-N 385812 US10287286, Example 214 Prolyl hydroxylase EGLN2 Homo sapiens 632 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385812&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540682 404854990 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772318 Cc1cc(ccc1-c1c(F)ccc2ncnn12)C#N InChI=1S/C14H9FN4/c1-9-6-10(7-16)2-3-11(9)14-12(15)4-5-13-17-8-18-19(13)14/h2-6,8H,1H3 UFFIQCONOMTRNB-UHFFFAOYSA-N 385813 US10287286, Example 215 Prolyl hydroxylase EGLN2 Homo sapiens 953 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385813&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540666 404854991 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772319 Fc1ccc2ncnn2c1-c1ccc(cc1F)C#N InChI=1S/C13H6F2N4/c14-10-3-4-12-17-7-18-19(12)13(10)9-2-1-8(6-16)5-11(9)15/h1-5,7H JCKPMHQVYXQULF-UHFFFAOYSA-N 385814 US10287286, Example 216 Prolyl hydroxylase EGLN2 Homo sapiens 997 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385814&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540632 404854992 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772320 Nc1cc(-c2ccc(cc2)C#N)n2ncnc2n1 InChI=1S/C12H8N6/c13-6-8-1-3-9(4-2-8)10-5-11(14)17-12-15-7-16-18(10)12/h1-5,7H,(H2,14,15,16,17) WUDVORRUGYLHKH-UHFFFAOYSA-N 385815 US10287286, Example 217 Prolyl hydroxylase EGLN2 Homo sapiens 376 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385815&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540585 404854993 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772321 Oc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C13H8N4O/c14-7-9-1-3-10(4-2-9)12-5-11(18)6-13-15-8-16-17(12)13/h1-6,8,18H FBDODZQVKOVCDF-UHFFFAOYSA-N 385816 US10287286, Example 218 Prolyl hydroxylase EGLN2 Homo sapiens 233 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385816&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540525 404854994 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772322 Oc1cc(-c2ccc(C#N)c(F)c2)n2ncnc2c1 InChI=1S/C13H7FN4O/c14-11-3-8(1-2-9(11)6-15)12-4-10(19)5-13-16-7-17-18(12)13/h1-5,7,19H GNOYFDYKXJPUML-UHFFFAOYSA-N 385820 US10287286, Example 219 Prolyl hydroxylase EGLN2 Homo sapiens 30.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385820&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540560 404854998 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772323 Cc1cc(C#N)c(F)cc1-c1cc(N)cc2ncnn12 InChI=1S/C14H10FN5/c1-8-2-9(6-16)12(15)5-11(8)13-3-10(17)4-14-18-7-19-20(13)14/h2-5,7H,17H2,1H3 KJJREHAQJJBUEW-UHFFFAOYSA-N 385821 US10287286, Example 220 Prolyl hydroxylase EGLN2 Homo sapiens 73.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385821&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540306 404854999 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772324 N#CN1CCN(CC1)c1cccc2ncnn12 InChI=1S/C11H12N6/c12-8-15-4-6-16(7-5-15)11-3-1-2-10-13-9-14-17(10)11/h1-3,9H,4-7H2 BTGQGTQMHPRCBE-UHFFFAOYSA-N 50239923 CHEMBL4100329::US10287286, Example 221 Prolyl hydroxylase EGLN2 Homo sapiens 1796 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239923&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 24857864 85715243 CHEMBL4100329 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772325 Fc1cc(cc(F)c1-c1cccc2ncnn12)C#N InChI=1S/C13H6F2N4/c14-9-4-8(6-16)5-10(15)13(9)11-2-1-3-12-17-7-18-19(11)12/h1-5,7H YFUPQNBWHXCVAW-UHFFFAOYSA-N 50239914 CHEMBL4078461::US10287286, Example 222 Prolyl hydroxylase EGLN2 Homo sapiens 161 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239914&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 10321088 85715427 CHEMBL4078461 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772326 Cc1c(F)c(ccc1-c1cccc2ncnn12)C#N InChI=1S/C14H9FN4/c1-9-11(6-5-10(7-16)14(9)15)12-3-2-4-13-17-8-18-19(12)13/h2-6,8H,1H3 DYYNCYBQURWPHG-UHFFFAOYSA-N 50239913 CHEMBL4102714::US10287286, Example 223 Prolyl hydroxylase EGLN2 Homo sapiens 52.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239913&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 21947643 85715382 CHEMBL4102714 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772327 COCc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C15H12N4O/c1-20-9-12-6-14(19-15(7-12)17-10-18-19)13-4-2-11(8-16)3-5-13/h2-7,10H,9H2,1H3 AYDGFDAMRGQULT-UHFFFAOYSA-N 385826 US10287286, Example 224 Prolyl hydroxylase EGLN2 Homo sapiens 3093 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385826&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540752 404855004 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772328 CC(=O)NCc1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C16H13N5O/c1-11(22)18-9-13-6-15(21-16(7-13)19-10-20-21)14-4-2-12(8-17)3-5-14/h2-7,10H,9H2,1H3,(H,18,22) XOVKTGISWRVRDQ-UHFFFAOYSA-N 385827 US10287286, Example 225 Prolyl hydroxylase EGLN2 Homo sapiens 1647 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385827&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540749 404855005 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772329 O=C(NCc1cc(-c2ccc(cc2)C#N)n2ncnc2c1)C1CC1 InChI=1S/C18H15N5O/c19-9-12-1-3-14(4-2-12)16-7-13(8-17-21-11-22-23(16)17)10-20-18(24)15-5-6-15/h1-4,7-8,11,15H,5-6,10H2,(H,20,24) DTZRLWJTMXBNFI-UHFFFAOYSA-N 385828 US10287286, Example 226 Prolyl hydroxylase EGLN2 Homo sapiens 135 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385828&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540334 404855006 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772330 Nc1ccc2ncnn2c1-c1ccc(cc1)C#N InChI=1S/C13H9N5/c14-7-9-1-3-10(4-2-9)13-11(15)5-6-12-16-8-17-18(12)13/h1-6,8H,15H2 JQSPRHORZWCDKZ-UHFFFAOYSA-N 50239930 CHEMBL4085560::US10287286, Example 227 Prolyl hydroxylase EGLN2 Homo sapiens 774 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50239930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50239930&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 44448489 85714513 CHEMBL4085560 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772331 Cc1c(F)c(ccc1-c1cc(N)cc2ncnn12)C#N InChI=1S/C14H10FN5/c1-8-11(3-2-9(6-16)14(8)15)12-4-10(17)5-13-18-7-19-20(12)13/h2-5,7H,17H2,1H3 VRQLLVZMWSYHPN-UHFFFAOYSA-N 385830 US10287286, Example 228 Prolyl hydroxylase EGLN2 Homo sapiens 68.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385830&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540608 404855008 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772332 Cc1nc(ccc1-c1c(F)ccc2ncnn12)C#N InChI=1S/C13H8FN5/c1-8-10(3-2-9(6-15)18-8)13-11(14)4-5-12-16-7-17-19(12)13/h2-5,7H,1H3 SSHKMJBQTVEESP-UHFFFAOYSA-N 385831 US10287286, Example 229 Prolyl hydroxylase EGLN2 Homo sapiens 3661 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385831&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540670 404855009 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772333 N#Cc1ccc(cc1)-c1cc(cc2ncnn12)N1CCNCC1 InChI=1S/C17H16N6/c18-11-13-1-3-14(4-2-13)16-9-15(22-7-5-19-6-8-22)10-17-20-12-21-23(16)17/h1-4,9-10,12,19H,5-8H2 NULNJTASVWHGGJ-UHFFFAOYSA-N 385832 US10287286, Example 230 Prolyl hydroxylase EGLN2 Homo sapiens 925 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385832&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540648 404855010 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772334 CC(=O)N1CCN(CC1)c1cc(-c2ccc(cc2)C#N)n2ncnc2c1 InChI=1S/C19H18N6O/c1-14(26)23-6-8-24(9-7-23)17-10-18(25-19(11-17)21-13-22-25)16-4-2-15(12-20)3-5-16/h2-5,10-11,13H,6-9H2,1H3 COLMJYBVAGMECJ-UHFFFAOYSA-N 385833 US10287286, Example 231 Prolyl hydroxylase EGLN2 Homo sapiens 199 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385833&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540590 404855011 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772335 Cc1cc(ccc1-c1cc(NCC(O)CO)cc2ncnn12)C#N InChI=1S/C17H17N5O2/c1-11-4-12(7-18)2-3-15(11)16-5-13(19-8-14(24)9-23)6-17-20-10-21-22(16)17/h2-6,10,14,19,23-24H,8-9H2,1H3 OVJABDQLRNCOTE-UHFFFAOYSA-N 385834 US10287286, Example 232 Prolyl hydroxylase EGLN2 Homo sapiens 74.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385834&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540312 404855012 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772336 CC(=O)Nc1cc(-c2ccc(C#N)c(F)c2C)n2ncnc2c1 InChI=1S/C16H12FN5O/c1-9-13(4-3-11(7-18)16(9)17)14-5-12(21-10(2)23)6-15-19-8-20-22(14)15/h3-6,8H,1-2H3,(H,21,23) MDNAODMPSFGANZ-UHFFFAOYSA-N 385835 US10287286, Example 233 Prolyl hydroxylase EGLN2 Homo sapiens 69.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385835&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540757 404855013 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772337 Fc1c(F)c(ccc1C#N)-c1cc(Cl)cc2ncnn12 InChI=1S/C13H5ClF2N4/c14-8-3-10(20-11(4-8)18-6-19-20)9-2-1-7(5-17)12(15)13(9)16/h1-4,6H SCANPRRUXSCKFM-UHFFFAOYSA-N 385836 US10287286, Example 234 Prolyl hydroxylase EGLN2 Homo sapiens 2113 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385836&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540460 404855014 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772338 Cc1cc(C#N)c(F)cc1-c1cc(Cl)cc2ncnn12 InChI=1S/C14H8ClFN4/c1-8-2-9(6-17)12(16)5-11(8)13-3-10(15)4-14-18-7-19-20(13)14/h2-5,7H,1H3 GMMZUSBSRMJYMT-UHFFFAOYSA-N 385837 US10287286, Example 235 Prolyl hydroxylase EGLN2 Homo sapiens 1690 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385837&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540583 404855015 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772339 Fc1cc(ccc1C#N)-c1cc(NC=O)cc2ncnn12 InChI=1S/C14H8FN5O/c15-12-3-9(1-2-10(12)6-16)13-4-11(18-8-21)5-14-17-7-19-20(13)14/h1-5,7-8H,(H,18,21) QVQTXFSQVFHTHR-UHFFFAOYSA-N 385838 US10287286, Example 236 Prolyl hydroxylase EGLN2 Homo sapiens 65.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385838&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122550626 404855016 C06049 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772340 Nc1nc(ccc1-c1cccc2ncnn12)C#N InChI=1S/C12H8N6/c13-6-8-4-5-9(12(14)17-8)10-2-1-3-11-15-7-16-18(10)11/h1-5,7H,(H2,14,17) ZECDLNVIDWWXMH-UHFFFAOYSA-N 385839 US10287286, Example 237 Prolyl hydroxylase EGLN2 Homo sapiens 89.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385839&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540572 404855017 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772341 Cc1cc(ccc1-c1cc(NC(=O)CO)cc2ncnn12)C#N InChI=1S/C16H13N5O2/c1-10-4-11(7-17)2-3-13(10)14-5-12(20-16(23)8-22)6-15-18-9-19-21(14)15/h2-6,9,22H,8H2,1H3,(H,20,23) YRHWYYWHPFKNTM-UHFFFAOYSA-N 385840 US10287286, Example 238 Prolyl hydroxylase EGLN2 Homo sapiens 96.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385840&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540720 404855018 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772342 Cc1cc(ccc1-c1cc(NC(=O)C(O)C(F)(F)F)cc2ncnn12)C#N InChI=1S/C17H12F3N5O2/c1-9-4-10(7-21)2-3-12(9)13-5-11(6-14-22-8-23-25(13)14)24-16(27)15(26)17(18,19)20/h2-6,8,15,26H,1H3,(H,24,27) DAQQJOMARAMDDQ-UHFFFAOYSA-N 385841 US10287286, Example 239 Prolyl hydroxylase EGLN2 Homo sapiens 333 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385841&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540401 404855019 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772343 Cc1cc(ccc1-c1cc(NC(=O)C(C)(C)O)cc2ncnn12)C#N InChI=1S/C18H17N5O2/c1-11-6-12(9-19)4-5-14(11)15-7-13(22-17(24)18(2,3)25)8-16-20-10-21-23(15)16/h4-8,10,25H,1-3H3,(H,22,24) FMODJHVQEMMQRV-UHFFFAOYSA-N 385842 US10287286, Example 240 Prolyl hydroxylase EGLN2 Homo sapiens 460 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385842&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540684 404855020 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772344 CC(=O)Nc1cc(-c2ccc(nc2C)C#N)n2ncnc2c1 InChI=1S/C15H12N6O/c1-9-13(4-3-11(7-16)19-9)14-5-12(20-10(2)22)6-15-17-8-18-21(14)15/h3-6,8H,1-2H3,(H,20,22) XITBTMQSRXIYDW-UHFFFAOYSA-N 385843 US10287286, Example 241 Prolyl hydroxylase EGLN2 Homo sapiens 152 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385843&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540419 404855021 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772345 CC(C)(C)OC(=O)Nc1cc(-c2ccc(cc2F)C#N)n2ncnc2c1 InChI=1S/C18H16FN5O2/c1-18(2,3)26-17(25)23-12-7-15(24-16(8-12)21-10-22-24)13-5-4-11(9-20)6-14(13)19/h4-8,10H,1-3H3,(H,23,25) VDXFKQSWHPKREZ-UHFFFAOYSA-N 385844 US10287286, Example 242 Prolyl hydroxylase EGLN2 Homo sapiens 381 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385844&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122550625 404855022 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772346 Fc1cc(ccc1C#N)-c1cc(NC(=O)C2CCO2)cc2ncnn12 InChI=1S/C17H12FN5O2/c18-13-5-10(1-2-11(13)8-19)14-6-12(7-16-20-9-21-23(14)16)22-17(24)15-3-4-25-15/h1-2,5-7,9,15H,3-4H2,(H,22,24) CXTIGGYEVMIHQJ-UHFFFAOYSA-N 385845 US10287286, Example 243 Prolyl hydroxylase EGLN2 Homo sapiens 1286 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385845&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540313 404855023 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772347 CC(=O)Nc1cc(-c2ccc(cc2F)C#N)n2ncnc2c1 InChI=1S/C15H10FN5O/c1-9(22)20-11-5-14(21-15(6-11)18-8-19-21)12-3-2-10(7-17)4-13(12)16/h2-6,8H,1H3,(H,20,22) JLBXPVLATDUNKH-UHFFFAOYSA-N 385846 US10287286, Example 244 Prolyl hydroxylase EGLN2 Homo sapiens 131 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385846&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540397 404855024 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772348 Fc1cc(ccc1-c1cc(NC(=O)C2CC2)cc2ncnn12)C#N InChI=1S/C17H12FN5O/c18-14-5-10(8-19)1-4-13(14)15-6-12(22-17(24)11-2-3-11)7-16-20-9-21-23(15)16/h1,4-7,9,11H,2-3H2,(H,22,24) GXMMIFQMKFWLCL-UHFFFAOYSA-N 385847 US10287286, Example 245 Prolyl hydroxylase EGLN2 Homo sapiens 107 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385847&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540581 404855025 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772349 COCCNc1cc(-c2ccc(cc2F)C#N)n2ncnc2c1 InChI=1S/C16H14FN5O/c1-23-5-4-19-12-7-15(22-16(8-12)20-10-21-22)13-3-2-11(9-18)6-14(13)17/h2-3,6-8,10,19H,4-5H2,1H3 DYBVVKHTQNXUPV-UHFFFAOYSA-N 385848 US10287286, Example 246 Prolyl hydroxylase EGLN2 Homo sapiens 65.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385848&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540369 404855026 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772350 CC(=O)Nc1cc(-c2cnc(cc2C)C#N)n2ncnc2c1 InChI=1S/C15H12N6O/c1-9-3-12(6-16)17-7-13(9)14-4-11(20-10(2)22)5-15-18-8-19-21(14)15/h3-5,7-8H,1-2H3,(H,20,22) KXWCZFKMDQFKHV-UHFFFAOYSA-N 385849 US10287286, Example 247 Prolyl hydroxylase EGLN2 Homo sapiens 80.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385849&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540614 404855027 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772351 Cc1cc(ncc1-c1cc(N)cc2ncnn12)C#N InChI=1S/C13H10N6/c1-8-2-10(5-14)16-6-11(8)12-3-9(15)4-13-17-7-18-19(12)13/h2-4,6-7H,15H2,1H3 XMKSYWRTYPXQRC-UHFFFAOYSA-N 385850 US10287286, Example 248 Prolyl hydroxylase EGLN2 Homo sapiens 35.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385850&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540688 404855028 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772352 Cc1cc(ccc1-c1cc(O)cc2ncnn12)C#N InChI=1S/C14H10N4O/c1-9-4-10(7-15)2-3-12(9)13-5-11(19)6-14-16-8-17-18(13)14/h2-6,8,19H,1H3 CIIIBQKLUPRIOO-UHFFFAOYSA-N 385851 US10287286, Example 249 Prolyl hydroxylase EGLN2 Homo sapiens 27.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385851&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540305 404855029 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772353 Cc1cc(ccc1-c1cc(NC(=O)C2CC2)cc2ncnn12)C#N InChI=1S/C18H15N5O/c1-11-6-12(9-19)2-5-15(11)16-7-14(22-18(24)13-3-4-13)8-17-20-10-21-23(16)17/h2,5-8,10,13H,3-4H2,1H3,(H,22,24) KSFLSVYCJRTRHZ-UHFFFAOYSA-N 385852 US10287286, Example 250 Prolyl hydroxylase EGLN2 Homo sapiens 88.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385852&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540368 404855030 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772354 Cc1nc(ccc1-c1cc(O)cc2ncnn12)C#N InChI=1S/C13H9N5O/c1-8-11(3-2-9(6-14)17-8)12-4-10(19)5-13-15-7-16-18(12)13/h2-5,7,19H,1H3 DGAOSOHXOVJROD-UHFFFAOYSA-N 385853 US10287286, Example 251 Prolyl hydroxylase EGLN2 Homo sapiens 17.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385853&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540314 404855031 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772355 Cc1cc(ccc1-c1cc(cc2ncnn12)N1CC2(COC2)C1)C#N InChI=1S/C19H17N5O/c1-13-4-14(7-20)2-3-16(13)17-5-15(6-18-21-12-22-24(17)18)23-8-19(9-23)10-25-11-19/h2-6,12H,8-11H2,1H3 CPQYTURIYBICGL-UHFFFAOYSA-N 385854 US10287286, Example 252 Prolyl hydroxylase EGLN2 Homo sapiens 1130 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385854&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540655 404855032 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772356 Cc1nc(ccc1-c1cc(NC(=O)C2CC2)cc2ncnn12)C#N InChI=1S/C17H14N6O/c1-10-14(5-4-12(8-18)21-10)15-6-13(22-17(24)11-2-3-11)7-16-19-9-20-23(15)16/h4-7,9,11H,2-3H2,1H3,(H,22,24) GJELYERIEMVYBK-UHFFFAOYSA-N 385855 US10287286, Example 253 Prolyl hydroxylase EGLN2 Homo sapiens 216 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385855&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540628 404855033 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772357 Cc1cc(C#N)c(F)cc1-c1cc(N)nc2ncnn12 InChI=1S/C13H9FN6/c1-7-2-8(5-15)10(14)3-9(7)11-4-12(16)19-13-17-6-18-20(11)13/h2-4,6H,1H3,(H2,16,17,18,19) SNQWVIHBHJUQLO-UHFFFAOYSA-N 385856 US10287286, Example 254 Prolyl hydroxylase EGLN2 Homo sapiens 751 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385856&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122550630 404855034 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772358 Nc1cc(-c2c(F)cc(cc2F)C#N)n2ncnc2c1 InChI=1S/C13H7F2N5/c14-9-1-7(5-16)2-10(15)13(9)11-3-8(17)4-12-18-6-19-20(11)12/h1-4,6H,17H2 ZPSOTUXICABJJK-UHFFFAOYSA-N 385857 US10287286, Example 255 Prolyl hydroxylase EGLN2 Homo sapiens 157 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385857&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540281 404855035 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772359 Cc1cc(ccc1-c1cc(NCC2CC2)nc2ncnn12)C#N InChI=1S/C17H16N6/c1-11-6-13(8-18)4-5-14(11)15-7-16(19-9-12-2-3-12)22-17-20-10-21-23(15)17/h4-7,10,12H,2-3,9H2,1H3,(H,19,20,21,22) WBOUVRGBXQBZFN-UHFFFAOYSA-N 385858 US10287286, Example 256 Prolyl hydroxylase EGLN2 Homo sapiens 92.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=385858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=385858&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540389 404855036 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772360 Cc1cc(ccc1-c1cc(N)nc2ncnn12)C#N InChI=1S/C13H10N6/c1-8-4-9(6-14)2-3-10(8)11-5-12(15)18-13-16-7-17-19(11)13/h2-5,7H,1H3,(H2,15,16,17,18) ZWPLNVSZMVYUJR-UHFFFAOYSA-N 386906 US10287286, Example 257 Prolyl hydroxylase EGLN2 Homo sapiens 165 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386906&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540302 404856041 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772361 Cc1cc(ccc1-c1cc(NC(=O)C2CC2(F)F)cc2ncnn12)C#N InChI=1S/C18H13F2N5O/c1-10-4-11(8-21)2-3-13(10)15-5-12(6-16-22-9-23-25(15)16)24-17(26)14-7-18(14,19)20/h2-6,9,14H,7H2,1H3,(H,24,26) GYZPCUWAXGVOOJ-UHFFFAOYSA-N 386907 US10287286, Example 258 Prolyl hydroxylase EGLN2 Homo sapiens 152 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386907&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540468 404856042 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772362 Nc1cc(-c2ccc(cc2Cl)C#N)n2ncnc2c1 InChI=1S/C13H8ClN5/c14-11-3-8(6-15)1-2-10(11)12-4-9(16)5-13-17-7-18-19(12)13/h1-5,7H,16H2 HFHKVUPJAOIPSX-UHFFFAOYSA-N 386908 US10287286, Example 259 Prolyl hydroxylase EGLN2 Homo sapiens 205 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386908&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540284 404856043 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772363 Nc1cc(-c2ccc(C#N)c(F)c2F)n2ncnc2c1 InChI=1S/C13H7F2N5/c14-12-7(5-16)1-2-9(13(12)15)10-3-8(17)4-11-18-6-19-20(10)11/h1-4,6H,17H2 DICBKTZZIMWZTR-UHFFFAOYSA-N 386909 US10287286, Example 260 Prolyl hydroxylase EGLN2 Homo sapiens 29.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386909&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540692 404856044 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772364 CC(=O)Nc1cc(-c2ccc(cc2Cl)C#N)n2ncnc2c1 InChI=1S/C15H10ClN5O/c1-9(22)20-11-5-14(21-15(6-11)18-8-19-21)12-3-2-10(7-17)4-13(12)16/h2-6,8H,1H3,(H,20,22) PHSYGPOCIUXUSY-UHFFFAOYSA-N 386910 US10287286, Example 261 Prolyl hydroxylase EGLN2 Homo sapiens 96.0 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386910&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540336 404856045 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14 772365 CC(=O)Nc1cc(-c2cc(F)c(cc2C)C#N)n2ncnc2c1 InChI=1S/C16H12FN5O/c1-9-3-11(7-18)14(17)6-13(9)15-4-12(21-10(2)23)5-16-19-8-20-22(15)16/h3-6,8H,1-2H3,(H,21,23) RLQSXFUVONKDKB-UHFFFAOYSA-N 386911 US10287286, Example 262 Prolyl hydroxylase EGLN2 Homo sapiens 108 US Patent 10.7270/Q2QJ7KMD aid1798645 US10287286 Ahmed, S; Barker, G; Canning, H; Davenport, R; Harrison, D; Jenkins, K; Livermore, D; Wright, S; Kinsella, N 5/14/2019 2/29/2020 Takeda Pharmaceutical Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=386911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5441&target=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=386911&enzyme=Prolyl+hydroxylase+EGLN2&column=ki&startPg=0&Increment=50&submit=Search 122540535 404856046 1 MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRKWAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALDYIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT Prolyl hydroxylase EGLN2 EGLN2_HUMAN Q96KS0 A8K5S0 Q8WWY4 Q9BV14